
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            ARSA Variants Associated With Cognitive Decline and Long‐Term Preservation of Motor Function in Metachromatic Leukodystrophy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7112189B705F31C11210029A4EFF6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Inherited Metabolic Disease">
<meta name="citation_title" content="ARSA Variants Associated With Cognitive Decline and Long‐Term Preservation of Motor Function in Metachromatic Leukodystrophy">
<meta name="citation_author" content="Shanice Beerepoot">
<meta name="citation_author_institution" content="Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children&#x27;s Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Nierkens and Lindemans Group, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands">
<meta name="citation_author" content="Daphne H Schoenmakers">
<meta name="citation_author_institution" content="Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children&#x27;s Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Platform “Medicine for Society”, Department of Endocrinology and Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Francesca Fumagalli">
<meta name="citation_author_institution" content="San Raffaele Telethon Institute for Gene Therapy (SR‐TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy">
<meta name="citation_author_institution" content="Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy">
<meta name="citation_author_institution" content="Neurology and Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy">
<meta name="citation_author" content="Samuel Groeschel">
<meta name="citation_author_institution" content="Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology and Social Paediatrics, University of Tübingen, University Hospital Tübingen, Tübingen, Germany">
<meta name="citation_author" content="Ludger Schöls">
<meta name="citation_author_institution" content="Department of Neurology and Hertie‐Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany">
<meta name="citation_author_institution" content="German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany">
<meta name="citation_author" content="Raphael Schiffmann">
<meta name="citation_author_institution" content="Texas Christian University, Fort Worth, Texas, USA">
<meta name="citation_author" content="Sheila Wong">
<meta name="citation_author_institution" content="Department of Pediatrics and Adolescent Medicine, Hong Kong Children&#x27;s Hospital, Hong Kong, China">
<meta name="citation_author" content="Odile Boespflug‐Tanguy">
<meta name="citation_author_institution" content="AP‐HP, Service de neuropédiatrie, French Reference Center for Leukodystrophies and Université Paris Cité, UMR 1141, INSERM, NeuroDiderot, Hopital Robert Debré, Paris, France">
<meta name="citation_author" content="Caroline Sevin">
<meta name="citation_author_institution" content="TIDU GENOV, Institut du Cerveau et de la Moelle Épinière, ICM, Inserm UMR 1127, CNRS UMR 7225, Sorbonne Université, Paris, France">
<meta name="citation_author_institution" content="Department of Neuropediatrics, French Reference Center for Leukodystrophies, Bicêtre Hospital, Paris, France">
<meta name="citation_author" content="Yann Nadjar">
<meta name="citation_author_institution" content="Neuro‐Metabolism Unit, Reference Center for Lysosomal and Metabolic Neurological Diseases, Department of Neurology, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France">
<meta name="citation_author" content="Annette Bley">
<meta name="citation_author_institution" content="Department of Pediatrics, Leukodystrophy Clinic, University Medical Center Hamburg Eppendorf, Hamburg, Germany">
<meta name="citation_author" content="Fanny Mochel">
<meta name="citation_author_institution" content="Reference Center for Neurometabolic Diseases and Leukodystrophies, Department of Medical Genetics, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France">
<meta name="citation_author" content="Morten A Horn">
<meta name="citation_author_institution" content="Department of Neurology, Oslo University Hospital, Oslo, Norway">
<meta name="citation_author" content="Cristina Baldoli">
<meta name="citation_author_institution" content="Neuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy">
<meta name="citation_author" content="Sara Locatelli">
<meta name="citation_author_institution" content="San Raffaele Telethon Institute for Gene Therapy (SR‐TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy">
<meta name="citation_author" content="Holger Hengel">
<meta name="citation_author_institution" content="Department of Neurology and Hertie‐Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany">
<meta name="citation_author" content="Lucia Laugwitz">
<meta name="citation_author_institution" content="Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology and Social Paediatrics, University of Tübingen, University Hospital Tübingen, Tübingen, Germany">
<meta name="citation_author" content="Carla E M Hollak">
<meta name="citation_author_institution" content="Platform “Medicine for Society”, Department of Endocrinology and Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Volkmar Gieselmann">
<meta name="citation_author_institution" content="Institute for Biochemistry and Molecular Biology, Medical Faculty, University of Bonn, Bonn, Germany">
<meta name="citation_author" content="Marjo S van der Knaap">
<meta name="citation_author_institution" content="Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children&#x27;s Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Center for Neurogenomics and Cognitive Research, Integrative Neurophysiology, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author" content="Nicole I Wolf">
<meta name="citation_author_institution" content="Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children&#x27;s Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands">
<meta name="citation_publication_date" content="2025 Aug 2">
<meta name="citation_volume" content="48">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70072">
<meta name="citation_doi" content="10.1002/jimd.70072">
<meta name="citation_pmid" content="40751594">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/pdf/JIMD-48-0.pdf">
<meta name="description" content="Patients with metachromatic leukodystrophy (MLD) show variable motor and cognitive decline. The ARSA variants c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln) and c.542T&gt;G, p.(Ile181Ser) are associated with predominantly cognitive decline. This ...">
<meta name="og:title" content="ARSA Variants Associated With Cognitive Decline and Long‐Term Preservation of Motor Function in Metachromatic Leukodystrophy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Patients with metachromatic leukodystrophy (MLD) show variable motor and cognitive decline. The ARSA variants c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln) and c.542T&gt;G, p.(Ile181Ser) are associated with predominantly cognitive decline. This ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12317651">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/jimd.70072"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/JIMD-48-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12317651%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12317651/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12317651/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/jimd.70072" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Inherit Metab Dis</button></div>. 2025 Aug 2;48(5):e70072. doi: <a href="https://doi.org/10.1002/jimd.70072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/jimd.70072</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Inherit%20Metab%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>ARSA</em> Variants Associated With Cognitive Decline and Long‐Term Preservation of Motor Function in Metachromatic Leukodystrophy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beerepoot%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shanice Beerepoot</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shanice Beerepoot</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Nierkens and Lindemans Group, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beerepoot%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shanice Beerepoot</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schoenmakers%20DH%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Daphne H Schoenmakers</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Daphne H Schoenmakers</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Platform “Medicine for Society”, Department of Endocrinology and Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schoenmakers%20DH%22%5BAuthor%5D" class="usa-link"><span class="name western">Daphne H Schoenmakers</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fumagalli%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Francesca Fumagalli</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Francesca Fumagalli</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>San Raffaele Telethon Institute for Gene Therapy (SR‐TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div class="p">
<sup>
<sup>6</sup>
</sup>Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div class="p">
<sup>
<sup>7</sup>
</sup>Neurology and Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fumagalli%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Fumagalli</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Groeschel%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Samuel Groeschel</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Samuel Groeschel</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology and Social Paediatrics, University of Tübingen, University Hospital Tübingen, Tübingen, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Groeschel%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Samuel Groeschel</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sch%C3%B6ls%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ludger Schöls</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ludger Schöls</span></h3>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Neurology and Hertie‐Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany</div>
<div class="p">
<sup>
<sup>10</sup>
</sup>German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sch%C3%B6ls%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Ludger Schöls</span></a>
</div>
</div>
<sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schiffmann%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Raphael Schiffmann</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Raphael Schiffmann</span></h3>
<div class="p">
<sup>
<sup>11</sup>
</sup>Texas Christian University, Fort Worth, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schiffmann%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Raphael Schiffmann</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wong%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sheila Wong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sheila Wong</span></h3>
<div class="p">
<sup>
<sup>12</sup>
</sup>Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wong%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sheila Wong</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boespflug%E2%80%90Tanguy%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Odile Boespflug‐Tanguy</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Odile Boespflug‐Tanguy</span></h3>
<div class="p">
<sup>
<sup>13</sup>
</sup>AP‐HP, Service de neuropédiatrie, French Reference Center for Leukodystrophies and Université Paris Cité, UMR 1141, INSERM, NeuroDiderot, Hopital Robert Debré, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boespflug%E2%80%90Tanguy%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Odile Boespflug‐Tanguy</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sevin%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Caroline Sevin</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Caroline Sevin</span></h3>
<div class="p">
<sup>
<sup>14</sup>
</sup>TIDU GENOV, Institut du Cerveau et de la Moelle Épinière, ICM, Inserm UMR 1127, CNRS UMR 7225, Sorbonne Université, Paris, France</div>
<div class="p">
<sup>
<sup>15</sup>
</sup>Department of Neuropediatrics, French Reference Center for Leukodystrophies, Bicêtre Hospital, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sevin%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Caroline Sevin</span></a>
</div>
</div>
<sup>14,</sup><sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nadjar%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yann Nadjar</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yann Nadjar</span></h3>
<div class="p">
<sup>
<sup>16</sup>
</sup>Neuro‐Metabolism Unit, Reference Center for Lysosomal and Metabolic Neurological Diseases, Department of Neurology, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nadjar%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yann Nadjar</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bley%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Annette Bley</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Annette Bley</span></h3>
<div class="p">
<sup>
<sup>17</sup>
</sup>Department of Pediatrics, Leukodystrophy Clinic, University Medical Center Hamburg Eppendorf, Hamburg, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bley%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Annette Bley</span></a>
</div>
</div>
<sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mochel%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Fanny Mochel</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Fanny Mochel</span></h3>
<div class="p">
<sup>
<sup>18</sup>
</sup>Reference Center for Neurometabolic Diseases and Leukodystrophies, Department of Medical Genetics, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mochel%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fanny Mochel</span></a>
</div>
</div>
<sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Horn%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Morten A Horn</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Morten A Horn</span></h3>
<div class="p">
<sup>
<sup>19</sup>
</sup>Department of Neurology, Oslo University Hospital, Oslo, Norway</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Horn%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Morten A Horn</span></a>
</div>
</div>
<sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baldoli%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Cristina Baldoli</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Cristina Baldoli</span></h3>
<div class="p">
<sup>
<sup>20</sup>
</sup>Neuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baldoli%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cristina Baldoli</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Locatelli%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Sara Locatelli</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Sara Locatelli</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>San Raffaele Telethon Institute for Gene Therapy (SR‐TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Locatelli%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sara Locatelli</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hengel%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Holger Hengel</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Holger Hengel</span></h3>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Neurology and Hertie‐Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hengel%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Holger Hengel</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Laugwitz%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Lucia Laugwitz</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Lucia Laugwitz</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology and Social Paediatrics, University of Tübingen, University Hospital Tübingen, Tübingen, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Laugwitz%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucia Laugwitz</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollak%20CEM%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Carla E M Hollak</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Carla E M Hollak</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Platform “Medicine for Society”, Department of Endocrinology and Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollak%20CEM%22%5BAuthor%5D" class="usa-link"><span class="name western">Carla E M Hollak</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gieselmann%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Volkmar Gieselmann</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Volkmar Gieselmann</span></h3>
<div class="p">
<sup>
<sup>21</sup>
</sup>Institute for Biochemistry and Molecular Biology, Medical Faculty, University of Bonn, Bonn, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gieselmann%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Volkmar Gieselmann</span></a>
</div>
</div>
<sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Knaap%20MS%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Marjo S van der Knaap</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Marjo S van der Knaap</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>22</sup>
</sup>Center for Neurogenomics and Cognitive Research, Integrative Neurophysiology, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Knaap%20MS%22%5BAuthor%5D" class="usa-link"><span class="name western">Marjo S van der Knaap</span></a>
</div>
</div>
<sup>1,</sup><sup>22</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolf%20NI%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Nicole I Wolf</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Nicole I Wolf</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolf%20NI%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicole I Wolf</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="jimd70072-aff-0001">
<sup>
<sup>1</sup>
</sup>Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands</div>
<div id="jimd70072-aff-0002">
<sup>
<sup>2</sup>
</sup>Amsterdam Neuroscience, Cellular &amp; Molecular Mechanisms, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div id="jimd70072-aff-0003">
<sup>
<sup>3</sup>
</sup>Nierkens and Lindemans Group, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands</div>
<div id="jimd70072-aff-0004">
<sup>
<sup>4</sup>
</sup>Platform “Medicine for Society”, Department of Endocrinology and Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div id="jimd70072-aff-0005">
<sup>
<sup>5</sup>
</sup>San Raffaele Telethon Institute for Gene Therapy (SR‐TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div id="jimd70072-aff-0006">
<sup>
<sup>6</sup>
</sup>Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div id="jimd70072-aff-0007">
<sup>
<sup>7</sup>
</sup>Neurology and Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div id="jimd70072-aff-0008">
<sup>
<sup>8</sup>
</sup>Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology and Social Paediatrics, University of Tübingen, University Hospital Tübingen, Tübingen, Germany</div>
<div id="jimd70072-aff-0009">
<sup>
<sup>9</sup>
</sup>Department of Neurology and Hertie‐Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany</div>
<div id="jimd70072-aff-0010">
<sup>
<sup>10</sup>
</sup>German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany</div>
<div id="jimd70072-aff-0011">
<sup>
<sup>11</sup>
</sup>Texas Christian University, Fort Worth, Texas, USA</div>
<div id="jimd70072-aff-0012">
<sup>
<sup>12</sup>
</sup>Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China</div>
<div id="jimd70072-aff-0013">
<sup>
<sup>13</sup>
</sup>AP‐HP, Service de neuropédiatrie, French Reference Center for Leukodystrophies and Université Paris Cité, UMR 1141, INSERM, NeuroDiderot, Hopital Robert Debré, Paris, France</div>
<div id="jimd70072-aff-0014">
<sup>
<sup>14</sup>
</sup>TIDU GENOV, Institut du Cerveau et de la Moelle Épinière, ICM, Inserm UMR 1127, CNRS UMR 7225, Sorbonne Université, Paris, France</div>
<div id="jimd70072-aff-0015">
<sup>
<sup>15</sup>
</sup>Department of Neuropediatrics, French Reference Center for Leukodystrophies, Bicêtre Hospital, Paris, France</div>
<div id="jimd70072-aff-0016">
<sup>
<sup>16</sup>
</sup>Neuro‐Metabolism Unit, Reference Center for Lysosomal and Metabolic Neurological Diseases, Department of Neurology, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France</div>
<div id="jimd70072-aff-0017">
<sup>
<sup>17</sup>
</sup>Department of Pediatrics, Leukodystrophy Clinic, University Medical Center Hamburg Eppendorf, Hamburg, Germany</div>
<div id="jimd70072-aff-0018">
<sup>
<sup>18</sup>
</sup>Reference Center for Neurometabolic Diseases and Leukodystrophies, Department of Medical Genetics, Pitié‐Salpêtrière University Hospital, AP‐HP, Paris, France</div>
<div id="jimd70072-aff-0019">
<sup>
<sup>19</sup>
</sup>Department of Neurology, Oslo University Hospital, Oslo, Norway</div>
<div id="jimd70072-aff-0020">
<sup>
<sup>20</sup>
</sup>Neuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy</div>
<div id="jimd70072-aff-0021">
<sup>
<sup>21</sup>
</sup>Institute for Biochemistry and Molecular Biology, Medical Faculty, University of Bonn, Bonn, Germany</div>
<div id="jimd70072-aff-0022">
<sup>
<sup>22</sup>
</sup>Center for Neurogenomics and Cognitive Research, Integrative Neurophysiology, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, the Netherlands</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Nicole I. Wolf (<span>n.wolf@amsterdamumc.nl</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 7; Received 2025 Jan 20; Accepted 2025 Jul 22; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Journal of Inherited Metabolic Disease</em> published by John Wiley &amp; Sons Ltd on behalf of SSIEM.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12317651  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40751594/" class="usa-link">40751594</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Patients with metachromatic leukodystrophy (MLD) show variable motor and cognitive decline. The <em>ARSA</em> variants c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln) and c.542T&gt;G, p.(Ile181Ser) are associated with predominantly cognitive decline. This multinational study analyzed MLD onset type, presenting signs/symptoms, cognitive function, gross motor function, central motor tract involvement, MRI severity score, peripheral neuropathy, and survival of 47 patients (three homozygous for c.256C&gt;T and five, twelve and 27 compound heterozygous for c.256C&gt;T, c.257G&gt;A, or c.542T&gt;G and another <em>ARSA</em> variant, respectively). Eleven underwent hematopoietic stem cell transplantation (HSCT). Onset was late‐juvenile (46.8%) or adult (44.7%) with predominantly cognitive decline (<em>n</em> = 40/41 symptomatic patients). At diagnosis, untreated patients typically retained independent walking (100%), sparing of central motor tracts (87.5%), and absence of demyelinating neuropathy (95.5%), which persisted in follow‐up for most (76.5%, 71.4%, and 64.7%, respectively). Early‐juvenile onset and rapid motor decline occurred only in patients compound heterozygous for c.256C&gt;T and a severe second variant (<em>n</em> = 4), showing central motor tract involvement at diagnosis. One untreated and one treated patient died of disease progression, and another from HSCT complications. All other treated patients retained independent walking, and four of five tested normal cognitive function. Median MRI severity score remained lower in treated (13) than untreated patients (25). The phenotype of c.256C&gt;T carriers depends on the severity of the second <em>ARSA</em> variant. Patients harboring c.257G&gt;A or c.542T&gt;G show late‐juvenile or adult onset with cognitive decline and preserved motor function, usually associated with sparing of central motor tracts. In these patients, cognitive function and MRI severity score should be preferred treatment outcomes.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> 
<em>ARSA</em> gene, arylsulfatase A, genetic association studies, hematopoietic stem cell transplantation, metachromatic leukodystrophy</p></section></section><section id="jimd70072-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Metachromatic leukodystrophy (MLD, MIM #250100) is a neurometabolic disorder caused by biallelic disease‐causing variants in <em>ARSA</em> (MIM*607574), resulting in deficiency of the lysosomal enzyme arylsulfatase A (ASA) and subsequent (lyso)sulfatides accumulation in the peripheral and central nervous system [<a href="#jimd70072-bib-0001" class="usa-link" aria-describedby="jimd70072-bib-0001">1</a>]. The clinical course of MLD is characterized by deterioration of gross and fine motor skills and cognitive function, ultimately leading to a severely disabled state and premature death [<a href="#jimd70072-bib-0002" class="usa-link" aria-describedby="jimd70072-bib-0002">2</a>, <a href="#jimd70072-bib-0003" class="usa-link" aria-describedby="jimd70072-bib-0003">3</a>, <a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>]. The rate of deterioration largely depends on the age of symptom onset (ASO), with a younger ASO resulting in a faster disease progression than an older ASO [<a href="#jimd70072-bib-0002" class="usa-link" aria-describedby="jimd70072-bib-0002">2</a>, <a href="#jimd70072-bib-0003" class="usa-link" aria-describedby="jimd70072-bib-0003">3</a>]. MLD has been classified into four onset types: late‐infantile (ASO: &lt; 30 months), early‐juvenile (ASO: 2.5–6 years), late‐juvenile (ASO: 7–16 years), and adult (ASO: &gt; 16 years) [<a href="#jimd70072-bib-0005" class="usa-link" aria-describedby="jimd70072-bib-0005">5</a>, <a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>]. This classification is used for defining study populations and determining eligibility for disease‐modifying treatments, either with allogeneic hematopoietic stem cell transplantation (HSCT) or autologous hematopoietic stem cell gene therapy (arsa‐cel). HSCT is considered the standard treatment for pre‐ and early‐symptomatic patients with late‐juvenile or adult‐onset MLD and has shown limited efficacy in early‐juvenile MLD. Arsa‐cel is approved for use in pre‐symptomatic late‐infantile and early‐juvenile patients, as well as in early‐symptomatic early‐juvenile cases [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0007" class="usa-link" aria-describedby="jimd70072-bib-0007">7</a>, <a href="#jimd70072-bib-0008" class="usa-link" aria-describedby="jimd70072-bib-0008">8</a>, <a href="#jimd70072-bib-0009" class="usa-link" aria-describedby="jimd70072-bib-0009">9</a>]. The type of symptoms at onset has been recognized as an additional clinical predictor of disease progression, with patients presenting with pure cognitive and behavioral symptoms exhibiting slower deterioration than patients presenting with motor symptoms. Some patients even retain normal motor function for decades without therapeutic intervention [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0010" class="usa-link" aria-describedby="jimd70072-bib-0010">10</a>]. These natural history data are important, not only for counseling and therapeutic decision making, but also for the evaluation of treatment effects in pre‐ and post‐registration studies, which often include motor function as a primary outcome [<a href="#jimd70072-bib-0011" class="usa-link" aria-describedby="jimd70072-bib-0011">11</a>]. In addition, identification of prognostic factors are essential to interpret results from future newborn screening in MLD [<a href="#jimd70072-bib-0012" class="usa-link" aria-describedby="jimd70072-bib-0012">12</a>].</p>
<p>Currently, the cause of clinical variation in MLD is not fully understood. A genotype–phenotype correlation has been proposed based on the predicted functionality of disease‐causing <em>ARSA</em> variants: variants resulting in very low or absent residual ASA activity (0‐alleles) are linked to early‐onset MLD phenotypes, while variants resulting in higher activity (R‐alleles) are associated with late‐onset phenotypes. Exact activity thresholds are not well defined and depend on assay sensitivity [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>, <a href="#jimd70072-bib-0010" class="usa-link" aria-describedby="jimd70072-bib-0010">10</a>, <a href="#jimd70072-bib-0013" class="usa-link" aria-describedby="jimd70072-bib-0013">13</a>, <a href="#jimd70072-bib-0014" class="usa-link" aria-describedby="jimd70072-bib-0014">14</a>, <a href="#jimd70072-bib-0015" class="usa-link" aria-describedby="jimd70072-bib-0015">15</a>, <a href="#jimd70072-bib-0016" class="usa-link" aria-describedby="jimd70072-bib-0016">16</a>]. Recently, Trinidad et al. proposed an MLD phenotype matrix, which classifies patients as late‐infantile, juvenile, adult, or asymptomatic based on variant classification as severe, moderate, or mild [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>]. Potential associations between disease‐causing <em>ARSA</em> variants and the type of symptoms at onset have also been reported, mainly in late‐juvenile and adult MLD. Most of these reports comprise isolated cases [<a href="#jimd70072-bib-0018" class="usa-link" aria-describedby="jimd70072-bib-0018">18</a>], except for compound heterozygosity for the common R‐allele c.542T&gt;G, p.(Ile181Ser) and other disease‐causing <em>ARSA</em> variants, which have repeatedly been linked to a cognitive onset [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0010" class="usa-link" aria-describedby="jimd70072-bib-0010">10</a>, <a href="#jimd70072-bib-0019" class="usa-link" aria-describedby="jimd70072-bib-0019">19</a>, <a href="#jimd70072-bib-0020" class="usa-link" aria-describedby="jimd70072-bib-0020">20</a>, <a href="#jimd70072-bib-0021" class="usa-link" aria-describedby="jimd70072-bib-0021">21</a>, <a href="#jimd70072-bib-0022" class="usa-link" aria-describedby="jimd70072-bib-0022">22</a>]. R‐allele c.256C&gt;T, p.(Arg86Trp) in homozygous state or compound heterozygous state with another disease‐causing <em>ARSA</em> variant has been associated with no or only mild peripheral neuropathy [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>]. Considering the current scarcity of genotype–phenotype associations in MLD and the increasing need for disease prediction in research and clinical settings, we aimed to further characterize clinical and MRI phenotypes of patients harboring the following variants—c.256C&gt;T, c.257G&gt;A p.(Arg86Gln), which alters the same amino acid as c.256C&gt;T, or c.542T&gt;G—and to examine the effect of treatment with HSCT in these patients.</p></section><section id="jimd70072-sec-0002"><h2 class="pmc_sec_title">2. Methods</h2>
<section id="jimd70072-sec-0003"><h3 class="pmc_sec_title">2.1. Standard Protocol Approvals and Patient Consents</h3>
<p>This cross‐sectional study was approved by the local ethics committees of each participating hospital. Written informed consent was obtained from the patients or their guardians.</p></section><section id="jimd70072-sec-0004"><h3 class="pmc_sec_title">2.2. Subjects</h3>
<p>Patients were included by the treating physician in 10 international centers (Amsterdam UMC, Baylor Scott &amp; White Research Institute, Hong Kong Children's Hospital, Robert Debré Hospital, Bicêtre Hospital, Pitié‐Salpêtrière University Hospital, University Medical Center Hamburg Eppendorf, University Hospital Tübingen, Oslo University Hospital, and IRCCS San Raffaele Scientific Institute). These centers span eight countries, with the European sites affiliated with the MLD Initiative—Disease Registry for MLD. Patients were eligible for the study if they had (1) a genetically and biochemically confirmed diagnosis of MLD [<a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>], or, if biochemical confirmation was not performed in family screening, identification of the same disease‐causing <em>ARSA</em> variants as in an affected sibling, and (2) at least one of the identified <em>ARSA</em> variants included c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln) or c.542T&gt;G, p.(Ile181Ser) in <em>ARSA</em>. Note that the numbering used here follows the GenBank <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000487.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000487.5</a> reference sequence, which differs by two amino acids compared to the original <a href="https://www.ncbi.nlm.nih.gov/nuccore/X52151.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">X52151.1</a> sequence and Uniprot entries, where c.256C&gt;T, p.(Arg86Trp), and c.257G&gt;A, p.(Arg86Gln) are referred to as c.250C&gt;T, p.(Arg84Trp), and c.251G&gt;A, p.(Arg84Gln), respectively, and c.542T&gt;G, p.(Ile181Ser) as c.536T&gt;G, p.(Ile179Ser).</p></section><section id="jimd70072-sec-0005"><h3 class="pmc_sec_title">2.3. Data Collection</h3>
<p>Clinical data on patient and treatment characteristics and test results at diagnosis and follow‐up (FU, latest clinical evaluation) were obtained as part of standard clinical care or prospective natural history studies (Table <a href="#jimd70072-supitem-0001" class="usa-link">S1</a>) [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0010" class="usa-link" aria-describedby="jimd70072-bib-0010">10</a>]. For each data point, FU in years was calculated from diagnosis for all patients, and disease duration was calculated from symptom onset for symptomatic patients. The functional severity of the disease‐causing <em>ARSA</em> variants identified in this study was classified based on Trinidad et al. [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>]. Based on this classification, c.256C&gt;T and c.257G&gt;A would be considered moderate variants, and c.542T&gt;G as a mild variant.</p></section><section id="jimd70072-sec-0006"><h3 class="pmc_sec_title">2.4. Assessments</h3>
<p>Assessments included MLD onset type, presenting signs and symptoms, gross motor function, cognitive function, involvement of the motor tracts on brain MRI, severity of MRI abnormalities, presence of peripheral neuropathy, and survival. MLD onset type was determined based on the ASO for symptomatic patients or based on the MLD onset type of a symptomatic sibling for the presymptomatic patients, according to previously published definitions [<a href="#jimd70072-bib-0005" class="usa-link" aria-describedby="jimd70072-bib-0005">5</a>, <a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>, <a href="#jimd70072-bib-0023" class="usa-link" aria-describedby="jimd70072-bib-0023">23</a>]. Presenting signs and symptoms were considered as the first problems noticed by the patient/family and were translated into five dichotomous variables: “presymptomatic,” “cognitive decline,” “psychiatric manifestations including behavioral abnormalities” [<a href="#jimd70072-bib-0024" class="usa-link" aria-describedby="jimd70072-bib-0024">24</a>], “impaired gross motor function,” and “other presentation.” Since different neuropsychological tests were used and subscores were not available, three cognitive levels based on full‐scale intelligence quotient (FSIQ) scores were defined: “no to borderline impaired cognitive function (FSIQ: ≥ 70),” “mildly impaired cognitive function (FSIQ: 50–69),” and “severely impaired cognitive function (FSIQ: ≤ 49)” [<a href="#jimd70072-bib-0025" class="usa-link" aria-describedby="jimd70072-bib-0025">25</a>]. In addition, patients with a FSIQ higher than 85 were analyzed separately as this threshold is suggested as treatment eligibility criterion [<a href="#jimd70072-bib-0026" class="usa-link" aria-describedby="jimd70072-bib-0026">26</a>]. Gross motor function was scored according to the validated Gross Motor Function Classification in MLD (GMFC‐MLD) [<a href="#jimd70072-bib-0027" class="usa-link" aria-describedby="jimd70072-bib-0027">27</a>]. As rapid decline of motor function has been associated with central motor tract involvement [<a href="#jimd70072-bib-0028" class="usa-link" aria-describedby="jimd70072-bib-0028">28</a>, <a href="#jimd70072-bib-0029" class="usa-link" aria-describedby="jimd70072-bib-0029">29</a>], we hypothesized that long‐term motor function preservation in these patients might correlate with sparing of the central motor tracts in MRI. Available neuroimaging was evaluated by local radiologists or (pediatric) neurologists, who assessed whether the white matter of the corticospinal tracts under the Rolandic area was visually “spared” or “not spared” on FLAIR images [<a href="#jimd70072-bib-0029" class="usa-link" aria-describedby="jimd70072-bib-0029">29</a>], independent of involvement of the posterior limb of the internal capsule (Figure <a href="#jimd70072-fig-0001" class="usa-link">1</a>). Severity of MRI abnormalities was scored using the MLD MRI severity score according to Eichler et al. [<a href="#jimd70072-bib-0030" class="usa-link" aria-describedby="jimd70072-bib-0030">30</a>]. Presence of peripheral neuropathy was determined based on nerve conduction study (NCS) and electromyography (EMG) reports stating whether the patient exhibited a demyelinating peripheral neuropathy and/or signs of axonal degeneration according to locally used criteria and reference values. Survival was calculated in years from birth to death for deceased patients and to last clinical evaluation for patients alive.</p>
<figure class="fig xbox font-sm" id="jimd70072-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f277/12317651/c8722911fad8/JIMD-48-0-g004.jpg" loading="lazy" id="jats-graphic-1" height="458" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/jimd70072-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MRI assessment of central motor tract involvement. Transverse FLAIR images illustrating central motor tract involvement at the posterior limb of the internal capsule (left) and the white matter under the Rolandic area (right). Upper panel: Images from a patient homozygous for the c.256C&gt;T, p.(Arg86Trp) variant with sparing of the central motor tracts, showing nearly normal signal intensity in the white matter of the corticospinal tracts under the Rolandic area at diagnosis at age 30 years (A) and follow‐up (FU) at age 37 years (B), despite surrounding abnormal white matter with increased signal intensity and abnormal signal in the internal capsule. Lower panel: Images from a patient compound heterozygous for c.256C&gt;T, p.(Arg86Trp), and c.465+1G&gt;A, p.(?) without sparing of the central motor tracts, displaying significantly increased signal intensity in the white matter of the corticospinal tracts under the Rolandic area at diagnosis at age 4 years (C) and FU at age 14 years (D), similar to the surrounding abnormal white matter and abnormal internal capsule.</p></figcaption></figure></section><section id="jimd70072-sec-0007"><h3 class="pmc_sec_title">2.5. Statistical Methods</h3>
<p>All patients were included in the analyses of assessments performed at diagnosis. Analyses of FU assessments were performed separately for patients treated with HSCT and those untreated. Categorical parameters were described by counts and percentages, while ordinal and continuous parameters were reported using median, interquartile range (iqr), and minimum–maximum ranges due to non‐normality, as determined graphically and with the Shapiro–Wilk test. Univariable analyses were conducted using Chi‐Square Test, Fisher's exact test, Mann–Whitney <em>U</em> Test, or Kruskal–Wallis multiple comparison with Benjamini‐Hochberg stepwise adjustment, as appropriate. All statistical tests were two‐tailed, and <em>p</em> values &lt; 0.05 were considered statistically significant. All analyses were performed using R version 4.3.2 (RStudio: Integrated Development for R. RStudio Inc., Boston, MA).</p></section></section><section id="jimd70072-sec-0008"><h2 class="pmc_sec_title">3. Results</h2>
<section id="jimd70072-sec-0009"><h3 class="pmc_sec_title">3.1. Patient Demographics</h3>
<p>The study population consisted of 47 patients with MLD, of whom 23 (48.9%) were male. There were eight sibling pairs. Eight patients (17.0%) carried the c.256C&gt;T variant, three of them in homozygous state. Twelve patients (25.5%) were compound heterozygous for c.257G&gt;A and another variant, and 27 (57.4%) were compound heterozygous for the c.542T&gt;G variant. The most common second disease‐causing <em>ARSA</em> variant in trans was a severe second variant, most often c.465 + 1G&gt;A, p.(?) (0‐allele), found in 72.3% of the patients. Individual patient demographics are shown in Table <a href="#jimd70072-supitem-0001" class="usa-link">S2</a>, including information on the functional severity classification of the second variant. Median age at diagnosis was 19 years (iqr: 12–31, range: 1–42 years). Most patients (<em>n</em> = 41, 87.3%) were symptomatic with a median ASO of 13 years (iqr: 8–26, range: 4–33 years). Eleven patients (23.4%) received HSCT at a median age of 17 years (iqr: 9–27, range: 4–35 years). Patient demographics for the separate <em>ARSA</em> variant groups are shown in Table <a href="#jimd70072-tbl-0001" class="usa-link">1</a>, which revealed no statistically significant differences between the groups, except that homozygosity was observed exclusively in patients with the <em>c.256C&gt;T</em> variant, not for the two other variants studied. There was only one patient who had an otherwise common mild <em>ARSA</em> variant, c.1283C&gt;T, in trans.</p>
<section class="tw xbox font-sm" id="jimd70072-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Patient demographics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">Variable<a href="#jimd70072-note-0005" class="usa-link">
<sup>a</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.256C&gt;T</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.257G&gt;A</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.542T&gt;G</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">
<em>p</em>
<a href="#jimd70072-note-0006" class="usa-link">
<sup>b</sup>
</a>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">(<em>n</em> = 8)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">(<em>n</em> = 12)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">(<em>n</em> = 27)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Male</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (37.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (50.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (51.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.851</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>ARSA</em> homozygosity</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (37.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.003</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Severe second variant<a href="#jimd70072-note-0007" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (50.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (66.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (81.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.190</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Residual ASA activity measurement</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (100)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (75.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (93.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.159</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Urinary sulfatide measurement</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (37.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (33.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (55.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.402</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Symptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (87.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (91.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (85.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age of onset, y</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (4–21)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (8–22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (12–28)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.200</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at diagnosis, y</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (4–33)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (11–29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (15–30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.513</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HSCT</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (12.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (25.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (25.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.801</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at HSCT, y</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (NA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (17–32)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (14–27)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA<a href="#jimd70072-note-0008" class="usa-link">
<sup>d</sup>
</a>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70072-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70072-note-0003"><p>
<em>Note:</em> Significant <em>p</em> values are indicated in bold.</p></div>
<div class="fn" id="jimd70072-note-0004"><p>Abbreviations: HSCT = allogeneic hematopoietic stem cell transplantation; NA = not assessed; y = years.</p></div>
<div class="fn" id="jimd70072-note-0005">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Values indicate median (interquartile range) or number (percent) unless otherwise stated.</p>
</div>
<div class="fn" id="jimd70072-note-0006">
<sup>
<sup>b</sup>
</sup><p class="display-inline">
<em>p</em> values were obtained with a Fisher's exact test or Kruskal–Wallis test as appropriate.</p>
</div>
<div class="fn" id="jimd70072-note-0007">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Functional severity of the second <em>ARSA</em> variants is indicated based on Trinidad et al. [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>].</p>
</div>
<div class="fn" id="jimd70072-note-0008">
<sup>
<sup>d</sup>
</sup><p class="display-inline">Differences in age at HSCT were not assessed due to the small patient numbers.</p>
</div>
</div></section></section><section id="jimd70072-sec-0010"><h3 class="pmc_sec_title">3.2. Assessments</h3>
<p>Table <a href="#jimd70072-tbl-0002" class="usa-link">2</a> summarizes assessments at the time of diagnosis for patients with the c.256C&gt;T, c.257G&gt;A, or c.542T&gt;G variant on one allele separately. Follow‐up data for untreated and treated patients are also presented separately for each variant group. While the second variants are functionally distinct, grouping was performed to investigate how patients with one of the c.256C&gt;T, c.257G&gt;A, or c.542T&gt;G variants present, irrespective of the second allele. Table <a href="#jimd70072-supitem-0001" class="usa-link">S2</a> provides a detailed overview of all patients, including the variants in trans. Table <a href="#jimd70072-supitem-0001" class="usa-link">S3</a> presents median disease duration at FU assessments for untreated patients across various outcomes, allowing for comparisons of disease duration differences between patients with distinct outcomes.</p>
<section class="tw xbox font-sm" id="jimd70072-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Measurements at diagnosis for all patients and at follow‐up for untreated and treated patients separately.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Variable<a href="#jimd70072-note-0010" class="usa-link">
<sup>a</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.256C&gt;T (<em>n</em> = 8)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.257G&gt;A (<em>n</em> = 12)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">c.542T&gt;G (<em>n</em> = 27)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Total (<em>n</em> = 47)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MLD onset type<a href="#jimd70072-note-0011" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/4/1/3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/8/4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/13/14</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/4/22/21</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Presenting symptoms</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (27)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (47)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cognitive decline</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (23)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (41)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Psychiatric manifestations</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (23)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (41)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Impaired gross motor function</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (23)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (41)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other additional symptoms</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (23)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (41)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cognitive function<a href="#jimd70072-note-0012" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/1</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/4/1</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/3/2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/7/4</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cognitive function FU UT<a href="#jimd70072-note-0012" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/1/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/1/4</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/2/8</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cognitive function FU TT<a href="#jimd70072-note-0012" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/1<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/1/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/1/1<sup>f</sup>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gross motor function<a href="#jimd70072-note-0013" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/2/0/0/0/1/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/1/0/0/0/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">27/0/0/0/0/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">41/3/0/0/0/1/0</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gross motor function FU UT<a href="#jimd70072-note-0013" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/0/0/0/0/0/4</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/3/0/0/0/2/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/3/1/1/0/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">20/6/1/1/0/2/4</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gross motor function FU TT<a href="#jimd70072-note-0013" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0/0/0/0/0/1</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/0/0/0/0/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/1/0/0/0/0/0</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/1/0/0/0/0/1</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Involvement of the motor tracts</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (42)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Involvement of the motor tracts FU UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (21)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Involvement of the motor tracts FU TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">1<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (11)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MRI severity</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (17–22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (13–20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (15–22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (15–22)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MRI severity FU UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 (22–31)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (22–24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (21–26)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (21–26)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MRI severity FU TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">33<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (NA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (13–15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (10–21)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (13–21)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Demyelinating neuropathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (29)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Demyelinating neuropathy FU UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (17)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Demyelinating neuropathy FU TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">0<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (7)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Axonal degenerative neuropathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (13)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (29)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Axonal degenerative neuropathy FU UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (17)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Axonal degenerative neuropathy FU TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">0<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (7)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Deceased UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (36)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Deceased TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">1<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Survival from birth UT</td>
<td align="center" valign="top" rowspan="1" colspan="1">42 (23–47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (19–36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (25–38)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (24–40)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Survival from birth TT</td>
<td align="center" valign="top" rowspan="1" colspan="1">9<a href="#jimd70072-note-0014" class="usa-link">
<sup>e</sup>
</a> (NA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38 (24–41)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (17–30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (14–34)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70072-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70072-note-0009"><p>Abbreviations: FU = follow‐up; HSCT = allogeneic hematopoietic stem cell transplantation; NA = not assessed; TT = treated; UT = untreated; y = years.</p></div>
<div class="fn" id="jimd70072-note-0010">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Values indicate median (interquartile range) or number (number of patients analyzed) unless otherwise stated.</p>
</div>
<div class="fn" id="jimd70072-note-0011">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Number of patients diagnosed with a late‐infantile/early‐juvenile/late‐juvenile/adult MLD phenotype.</p>
</div>
<div class="fn" id="jimd70072-note-0012">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Cognitive function was only determined in patients with available full‐scale intelligence quotient scores and categories are presented as “no to borderline impaired cognitive function”/“mildly impaired cognitive function”/“severely impaired cognitive function.”</p>
</div>
<div class="fn" id="jimd70072-note-0013">
<sup>
<sup>d</sup>
</sup><p class="display-inline">Gross motor function are categories are presented as “GMFC‐MLD = 0”/“GMFC‐MLD = 1”/“GMFC‐MLD = 2”/“GMFC‐MLD = 3”/“GMFC‐MLD = 4”/“GMFC‐MLD = 5”/“GMFC‐MLD = 6.”</p>
</div>
<div class="fn" id="jimd70072-note-0014">
<sup>
<sup>e</sup>
</sup><p class="display-inline">Patient who died due to disease progression after HSCT failure.</p>
</div>
</div></section></section><section id="jimd70072-sec-0011"><h3 class="pmc_sec_title">3.3. 
MLD Onset Type</h3>
<p>Most patients had either adult (<em>n</em> = 21, 44.7%) or late‐juvenile (<em>n</em> = 22, 46.8%) MLD. None of the patients had late‐infantile MLD. Four patients (10.3%) had early‐juvenile MLD, all of whom were compound heterozygous for c.256C&gt;T and a severe second variant according to Trinidad et al. [<a href="#jimd70072-bib-0016" class="usa-link" aria-describedby="jimd70072-bib-0016">16</a>]. No severe second variants were found in trans in the late‐juvenile and adult patients carrying the c.256C&gt;T variant, whereas severe variants <em>in trans</em> were common in the late‐juvenile and adult patients carrying the c.257G&gt;A or c.542T&gt;G variant. Figure <a href="#jimd70072-fig-0002" class="usa-link">2</a> depicts the distribution and functional severity of second <em>ARSA</em> variants among the MLD onset types within the three groups.</p>
<figure class="fig xbox font-sm" id="jimd70072-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f277/12317651/dad4bf83de0c/JIMD-48-0-g001.jpg" loading="lazy" id="jats-graphic-3" height="428" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/jimd70072-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution and severity of <em>ARSA</em> variants identified in this study and location of affected amino acid residues. (A) Donut chart illustrating the proportion of patients with MLD onset types within the c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln), and c.542T&gt;G, p.(Ile181Ser) groups. The distribution of the second <em>ARSA</em> variants per MLD onset type is shown across these groups. Functional severity of the second <em>ARSA</em> variants is indicated based on Trinidad et al., with known severe variants in red, known mild or moderate variants in black, and variants with unknown functional severity in blue. Asterisks (*) denote conflicting interpretations of functional severity. (B) 3D model of the ASA monomer (Protein Data Bank 1AUK, visualized using the PyMOL Molecular Graphics System, Version 3.0.3 Schrödinger LLC [<a href="#jimd70072-bib-0031" class="usa-link" aria-describedby="jimd70072-bib-0031">31</a>]) depicting the locations of amino acid residue Arg86 (blue, affected by the c.256C&gt;T and c.257G&gt;A variants) and Ile181 (yellow, affected by the c.542T&gt;G variant) and three other commonly affected amino acid residues in MLD: Pro428, commonly affected in patients with late‐juvenile and adult MLD, is orange. Gly124 and Gly310, affected in patients with late‐infantile MLD, are red. Amino acid residues forming the active center of ASA are highlighted in teal. Helices, β‐sheets, and loops are represented as ribbons, arrows, and threads, respectively.</p></figcaption></figure></section><section id="jimd70072-sec-0012"><h3 class="pmc_sec_title">3.4. Presenting Signs and Symptoms</h3>
<p>Six patients, diagnosed because of symptomatic family members, were asymptomatic at presentation. Of the 41 symptomatic patients, 40 presented with cognitive decline, either alone (<em>n</em> = 6, 15.0%) or with additional symptoms (<em>n</em> = 34, 85.0%), with psychiatric manifestations being the most prevalent (<em>n</em> = 32). Figure <a href="#jimd70072-fig-0003" class="usa-link">3</a> displays the distribution of all combinations of presenting signs and symptoms. One patient, homozygous for c.256C&gt;T, presented exclusively with psychiatric manifestations at age 31 years. Only one patient (2.4%), compound heterozygous for c.256C&gt;T and a severe second variant in trans, presented with impaired gross motor function (balance problems at the age of 3.9 years), in addition to cognitive decline.</p>
<figure class="fig xbox font-sm" id="jimd70072-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f277/12317651/6ed64f0c742c/JIMD-48-0-g002.jpg" loading="lazy" id="jats-graphic-5" height="316" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/jimd70072-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of presenting signs and symptoms. Black dots represent individual presenting signs and symptoms or combinations of them (multiple black dots connected). The total bar length indicates the total number of patients with each combination. Separate colored bars show the number of patients with each combination per <em>ARSA</em> variant included in the study. Other presenting signs and symptoms were impaired fine motor skills in two patients (one early‐juvenile patient compound heterozygous for c.256C&gt;T, p.(Arg86Trp) and one late‐juvenile patient compound heterozygous for c.257G&gt;A, p.(Arg86Gln), both harboring a severe second variant in trans) and spasticity in one late‐juvenile patient (compound heterozygous for c.257G&gt;A, p.(Arg86Gln) and a severe second variant in trans).</p></figcaption></figure></section><section id="jimd70072-sec-0013"><h3 class="pmc_sec_title">3.5. Cognitive Function</h3>
<p>FSIQ was measured at diagnosis for 21/47 patients. Four patients (19.1%) had severe, seven (33.3%) had mild, and ten (47.6%) had no to borderline cognitive impairment (Figure <a href="#jimd70072-fig-0004" class="usa-link">4A</a>). Of these ten patients, five had an FSIQ above 85 and were still presymptomatic.</p>
<figure class="fig xbox font-sm" id="jimd70072-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f277/12317651/f44333d7c3b8/JIMD-48-0-g003.jpg" loading="lazy" id="jats-graphic-7" height="869" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/jimd70072-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of measurements at diagnosis and follow‐up, with separated analysis for untreated and HSCT‐treated patients. (A–C, E, F) Bar graphs show patient counts and percentages by category at diagnosis and follow‐up (FU). Colored lines connect individual patients to their respective categories, while unconnected lines within the red boxes indicate no assessments at diagnosis (NA) and/or FU (NA at FU). X's denote the two patients who died due to HSCT complications (pink) or MLD progression after unsuccessful HSCT due to engraftment failure (orange). (D) Box plots display median and iqr at diagnosis and FU, with dots representing individual patients and lines connecting their measurements at diagnosis and FU. (A) Cognitive function categories: No to borderline impairment (FSIQ ≥ 70), mild impairment (FSIQ 50–69), and severe impairment (FSIQ ≤ 49). (B) Gross Motor Function according to the GMFC‐MLD scale with score 0 indicating normal locomotion and score 6 indicating loss of all gross motor function; no patients scored 4. (C) Central motor tracts sparing: Yes/No, based on whether the white matter of the corticospinal tracts under the Rolandic area was visually “spared” or “not spared”, independent of involvement of the posterior limb of the internal capsule. (D) MLD MRI severity score with score 0 indicating no MRI abnormalities and score 34 most severe MRI abnormalities: The median annual increase in MRI severity score was 1.0 in the untreated group and 0.3 in the treated group. (E) Demyelinating neuropathy and (F) Signs of axonal degeneration on nerve conduction studies and electromyography: Yes/No, according to locally used criteria and reference values.</p></figcaption></figure><p>At FU, 11 untreated patients were tested (Figure <a href="#jimd70072-fig-0004" class="usa-link">4A</a>). Eight had severe cognitive impairment (all but one with an FSIQ ≤ 40; three already had an FSIQ ≤ 40 at diagnosis). Two had mild cognitive impairment: in one patient, FSIQ dropped from 67 to 54 over 3.5 years, and the other had an FSIQ of 61 after 14.8 years with no prior measurement. One patient, compound heterozygous for c.542T&gt;G, had an FSIQ of 92 after 4 years, despite reported cognitive decline at diagnosis without an initial FSIQ measurement. There were no differences between genotype groups or second variant severity.</p></section><section id="jimd70072-sec-0014"><h3 class="pmc_sec_title">3.6. Gross Motor Function and Sparing of the Central Motor Tracts</h3>
<p>At diagnosis, 41/44 (93.2%) had a GMFC‐MLD score of 0, while three (6.8%) had a score of 1, indicating mild gait abnormalities (Figure <a href="#jimd70072-fig-0004" class="usa-link">4B</a>). All patients with mild motor signs were compound heterozygous for a severe second variant and showed central motor tract involvement. Of all 43 patients with neuroimaging data at diagnosis, 36 (83.7%) demonstrated sparing of the central motor tracts (Figure <a href="#jimd70072-fig-0004" class="usa-link">4C</a>), more commonly in those harboring the c.257G&gt;A (100%) or c.542T&gt;G (88.0%) variant, compared to those harboring the c.256C&gt;T variant (50.0%). In the latter groups, involvement of the motor tracts was associated with a severe variant in trans in most patients (Table <a href="#jimd70072-supitem-0001" class="usa-link">S2</a>).</p>
<p>During FU, the majority of the untreated patients (26/34, 76.5%) retained independent walking ability with a GMFC‐MLD score of 0 (<em>n =</em> 20) or 1 (<em>n</em> = 6) (Figure <a href="#jimd70072-fig-0004" class="usa-link">4B</a>). Six patients (17.7%) lost all locomotion, including all three who had mild motor impairment (score 1) at diagnosis. Among these, all four patients who were compound heterozygous for c.256C&gt;T and a severe second variant deteriorated to GMFC‐MLD 6, while all patients homozygous for c.256C&gt;T maintained GMFC‐MLD 0. In patients harboring the c.257G&gt;A or c.542T&gt;G variant, a severe second variant was not associated with motor decline (<em>p</em> = 0.407). However, the only two patients with GMFC‐MLD 5 were compound heterozygous for c.257G&gt;A and a severe second variant, with one of them presenting a score of 1 at diagnosis. Gross motor decline was associated with central motor tract involvement at diagnosis (<em>p</em> &lt; 0.001) and FU (<em>p</em> = 0.006) in all groups. Central motor tract involvement was observed only in patients with a severe second <em>ARSA</em> variant. Importantly, repeated neuroimaging in 21 untreated patients revealed that, except for two cases, all patients with initial central motor tract sparing maintained this sparing at FU, with a maximum FU duration of 21 years (Figure <a href="#jimd70072-fig-0004" class="usa-link">4C</a>).</p>
<p>There was no significant difference in disease duration between patients who experienced motor decline and those who did not (<em>p</em> = 0.493), nor between those with and without central motor tract sparing (<em>p</em> = 0.533).</p></section><section id="jimd70072-sec-0015"><h3 class="pmc_sec_title">3.7. 
MRI Severity</h3>
<p>The median MLD MRI severity score at diagnosis was 19 (iqr: 15–22, range: 0–26, Figure <a href="#jimd70072-fig-0004" class="usa-link">4D</a>) and was comparable among patients harboring one of the three variants (<em>p</em> = 0.746), regardless of a severe second variant in trans (<em>p</em> = 0.531).</p>
<p>In most untreated patients (88.2%), MLD MRI severity score was increased at FU, resulting in a median score of 25 (iqr: 21–26, range: 16–34, Figure <a href="#jimd70072-fig-0004" class="usa-link">4D</a>). The median increase per year was 1.0, and both total increase and increase rate were comparable among patients carrying one of the three variants (<em>p</em> = 0.679 and <em>p</em> = 0.452, respectively). Patients carrying a severe second variant in trans tended to have higher MRI severity scores (median: 26) and a greater annual increase (median: 0.8) than those carrying a mild or moderate second variant (median score: 23, median increase: 0.3, <em>p</em> = 0.100). Patients carrying a second variant of unknown functional severity exhibited the highest annual increase (median: 1.5, <em>p</em> = 0.044).</p></section><section id="jimd70072-sec-0016"><h3 class="pmc_sec_title">3.8. Presence of Peripheral Neuropathy</h3>
<p>Twenty‐nine patients underwent NCS at diagnosis. Four (13.8%) were diagnosed with demyelinating neuropathy, while five (17.2%) different patients showed signs of axonal involvement without fulfilling the local diagnostic criteria for a demyelinating neuropathy (Figure <a href="#jimd70072-fig-0004" class="usa-link">4E,F</a>). One of these later was diagnosed with demyelinating neuropathy at FU.</p>
<p>At FU, among the 17 untreated patients tested, the proportion of patients diagnosed with demyelinating neuropathy and those with axonal degeneration both increased to 35.3% (Figure <a href="#jimd70072-fig-0004" class="usa-link">4E,F</a>). Half of these patients were diagnosed with both. There were no differences between genotype groups or second variant severity.</p></section><section id="jimd70072-sec-0017"><h3 class="pmc_sec_title">3.9. Survival</h3>
<p>One (2.8%) untreated patient, who was compound heterozygous for c.256C&gt;T and a severe second variant, died of disease progression 4.8 years after onset, at the age of 10.3 years. The remaining 36 (97.3%) untreated patients were alive, with a median survival of 34.2 years (iqr: 24.9–39.8, range: 10.3–52.1). While survival did not vary between genotype groups, the presence of a severe second variant was linked to a significantly shorter survival duration (<em>p</em> &lt; 0.001). This was attributed to a younger age at the time of the study, as death occurred in only one untreated patient.</p></section><section id="jimd70072-sec-0018"><h3 class="pmc_sec_title">3.10. Effects of HSCT
</h3>
<p>Eleven patients were treated with HSCT (Table <a href="#jimd70072-tbl-0003" class="usa-link">3</a>). Except for two patients (#257‐11 and #542‐8) with a second <em>ARSA</em> variant of unknown functional severity according to Trinidad et al. [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>], all of them carried a severe second variant in trans. Two late‐juvenile patients (#257‐11 and #542‐1) and three adult patients (#257‐3, #542‐3, and #542‐21) were presymptomatic at the time of treatment. One early‐juvenile patient (#256‐3) exhibited cognitive impairment and impaired fine motor skills, with onset occurring 6 months before treatment. Three late‐juvenile patients (#542‐8, #542‐22, and #542‐24) and two adult patients (#257‐2 and #542‐6) displayed cognitive and psychiatric signs and symptoms, with onset ranging from 1.5 to 7.0 years prior to treatment. Except for patient #256‐3, whose GMFC‐MLD score was unknown, all patients had a GMFC‐MLD score of 0 at the time of treatment. All patients with available FSIQ data (#257‐2, #257‐3, #542‐1, #542‐3, #542‐8, and #542‐21) exhibited no to borderline impaired cognitive function. The central motor tracts were spared in all patients except #256‐3, #542‐22, and #542‐24. Patients #542‐3, #542‐6, and #542‐22 had a demyelinating neuropathy, whereas patients #256‐3, #257‐2, #257‐3, #257‐11, and #542‐21 did not.</p>
<section class="tw xbox font-sm" id="jimd70072-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Clinical characteristics and outcomes of individual treated patients before and after HSCT.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Patient ID</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Symptoms (ASO)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Onset type</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Age HSCT<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">GMFC‐MLD (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cognitive function<a href="#jimd70072-note-0018" class="usa-link">
<sup>b</sup>
</a> (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Involvement of the motor tracts (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">MRI severity score (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Demyelinating peripheral neuropathy (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Axonal degeneration (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Deceased (treatment FU<a href="#jimd70072-note-0017" class="usa-link">
<sup>a</sup>
</a>)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">256‐3</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, impaired fine motor skills (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">EJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/6 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/Severe (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/Yes (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/33 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Yes (5)</p>
<p>Disease progression after engraftment failure</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">257‐2</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, psychiatric manifestations (25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/17 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (10)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">257‐3</td>
<td align="center" valign="top" rowspan="1" colspan="1">Presymptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">35</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/13 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/Yes (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (11)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">257‐11</td>
<td align="center" valign="top" rowspan="1" colspan="1">Presymptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">LJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/Mild (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/12 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (4)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐1</td>
<td align="center" valign="top" rowspan="1" colspan="1">Presymptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">LJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/No (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/No (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (9)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐3</td>
<td align="center" valign="top" rowspan="1" colspan="1">Presymptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">26</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/13 (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/No (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/Yes (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (11)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐6</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, psychiatric manifestations (29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">31</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/13 (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (&lt; 1)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐8</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, psychiatric manifestations (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">LJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/20 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Yes (&lt; 1)</p>
<p>HSCT related</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐21</td>
<td align="center" valign="top" rowspan="1" colspan="1">Presymptomatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">29</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/No (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Spared/Spared (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/7 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (&lt; 1)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐22</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, psychiatric manifestations (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">LJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">18</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/0 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/Yes (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/22 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No/NA (−)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (&lt; 1)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">542‐24</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline, psychiatric manifestations (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">LJ</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/1 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/No (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes/Yes (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23/23 (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/No (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA/No (&lt; 1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No (&lt; 1)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70072-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70072-note-0015"><p>
<em>Note:</em> Clinical characteristics and outcomes of individual treated patients are shown. For GMFC‐MLD, cognitive function, involvement of the motor tracts, MRI severity score, demyelinating peripheral neuropathy, and axonal degeneration, the outcome at diagnosis and at latest follow‐up is presented. For outcomes at latest follow‐up, the treatment follow‐up is indicated between brackets. Survival is calculated from treatment to death for deceased patients and to last clinical evaluation for living patients. &lt; 1 indicate that the last evaluation was within the first year after HSCT.</p></div>
<div class="fn" id="jimd70072-note-0016"><p>Abbreviations: A = adult; ASO = age of symptom onset; EJ = early‐juvenile; FU = follow‐up; HSCT = allogeneic hematopoietic stem cell transplantation; LI = late‐infantile; LJ = late‐juvenile; NA = not assessed.</p></div>
<div class="fn" id="jimd70072-note-0017">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Age and treatment follow‐up are given in years.</p>
</div>
<div class="fn" id="jimd70072-note-0018">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Cognitive function categories are presented as “no” indicating “no to borderline impaired cognitive function”; “mild” indicating “mildly impaired cognitive function.”</p>
</div>
</div></section><p>One patient (#542‐8) died from HSCT complications at the age of 13 years, one patient (#256–3) at the age of 9.4 years due to disease progression, 5 years after unsuccessful HSCT due to engraftment failure. The remaining nine patients were still alive at a median age of 29 years (iqr: 16–37, range: 9.5–44), in stable neurological condition, following initial disease progression shortly after HSCT in some cases (#257‐3 and #542‐24).</p>
<p>Presymptomatic patient #257–3, who had an MRI score of 10 before HSCT, developed cognitive and psychiatric signs and symptoms within the first year after treatment, with an FSIQ drop from 87 to 73. The four other presymptomatic patients (#257‐11, #542‐1, #542‐3, and #542‐21) remained without symptoms at ages 9.5, 15.5, 37.4, and 29.0 years, respectively, with stable neuropsychological testing. Symptomatic patient #542‐24 progressed to a GMFC‐MLD score of 1 immediately after HSCT, while all other surviving patients maintained a GMFC‐MLD score of 0.</p>
<p>In all patients whose central motor tracts were spared at the time of treatment, these tracts remained spared at FU. The MRI severity score remained stable in three patients (33.3%), including a score of 0 in patient #542‐1 after 8.5 years post‐HSCT at age 15.5 years. The score increased by three or fewer points in five patients (55.6%) and by five points in one patient (#257‐2, 11.1%), resulting in a median MRI severity score of 13 (iqr: 12–17, range: 0–23). The median increase per year was 0.3. None of the seven patients tested were diagnosed with demyelinating neuropathy, but two (28.6%) developed signs of axonal degeneration.</p></section></section><section id="jimd70072-sec-0019"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This study compares clinical phenotypes of 47 patients with MLD harboring c.256C&gt;T, p.(Arg86Trp), c.257G&gt;A, p.(Arg86Gln) or c.542T&gt;G, p.(Ile181Ser) in <em>ARSA</em> and examines the effect of HSCT on the disease course in eleven of them. In line with previous reports, our data reveal that the phenotype of these patients is characterized by mainly cognitive decline, often accompanied by psychiatric manifestations, including behavioral problems.</p>
<p>All patients harboring the <em>ARSA</em> variants c.257G&gt;A or c.542T&gt;G in compound heterozygous state, or c.256C&gt;T in homozygous state, had a late‐juvenile or adult MLD onset of cognitive decline. Even without treatment, most patients retained independent walking, with sparing of the central motor tracts up to 30 years after onset. Notably, more than two‐thirds of these patients carried a severe second <em>ARSA</em> variant in trans. Still, the age of onset was variable in this patient group, ranging from 6 to 33 years. Our findings are consistent with previous reports on untreated patients with these genotypes [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0010" class="usa-link" aria-describedby="jimd70072-bib-0010">10</a>, <a href="#jimd70072-bib-0019" class="usa-link" aria-describedby="jimd70072-bib-0019">19</a>, <a href="#jimd70072-bib-0020" class="usa-link" aria-describedby="jimd70072-bib-0020">20</a>, <a href="#jimd70072-bib-0021" class="usa-link" aria-describedby="jimd70072-bib-0021">21</a>, <a href="#jimd70072-bib-0022" class="usa-link" aria-describedby="jimd70072-bib-0022">22</a>, <a href="#jimd70072-bib-0032" class="usa-link" aria-describedby="jimd70072-bib-0032">32</a>], although these studies did not analyze the involvement of the central motor tracts. Why these tracts are spared and remain so is not known.</p>
<p>A severe second <em>ARSA</em> variant according to Trinidad et al. was associated with a more severe clinical presentation only in patients harboring the c.256C&gt;T variant in a compound heterozygous state [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>]. These patients exhibited an early‐juvenile MLD onset of cognitive decline, followed by rapid motor deterioration. MRI showed corticospinal tract involvement already at diagnosis in all of them. This observation aligns with previous findings that central motor region involvement based on FA values in the pyramidal tracts or spatial distribution of demyelination load predicts a more severe disease progression [<a href="#jimd70072-bib-0028" class="usa-link" aria-describedby="jimd70072-bib-0028">28</a>, <a href="#jimd70072-bib-0029" class="usa-link" aria-describedby="jimd70072-bib-0029">29</a>]. Our study suggests that central motor tract involvement is associated with the <em>ARSA</em> genotype.</p>
<p>Nine of the eleven HSCT‐treated patients were alive at the time of the study, all retaining the ability to walk independently, and four out of the five tested had normal cognitive function. Additionally, MRI severity scores at FU were lower in the HSCT group than in the untreated group. While this difference may partly reflect lower initial scores at diagnosis, the median annual increase in MRI severity scores was also reduced in the HSCT group. Typically, MRI severity scores increase during the first year after HSCT and stabilize or decrease in subsequent years [<a href="#jimd70072-bib-0033" class="usa-link" aria-describedby="jimd70072-bib-0033">33</a>], resulting in larger differences between treated and untreated patients after longer FU. It is important to note that two treated patients died following HSCT, resulting in a survival rate of 81.8%. One death was due to complications, illustrating the inherent risks of HSCT, while the other occurred due to disease progression after engraftment failure, reflecting the natural disease course in patients compound heterozygous for c.256C&gt;T and a severe second variant. In contrast, all but one of the untreated patients remained alive, with a median survival of 34 years. However, longer follow‐up is needed to fully assess the long‐term benefits of HSCT, particularly with regard to motor function and survival, given the slow progression of the disease associated with these <em>ARSA</em> variants.</p>
<p>Our study exemplifies that disease prediction based on genotype in cases of compound heterozygosity involving a 0‐ and R‐allele, or combination of severe and mild or moderate functional severity as defined by Trinidad et al. is not straightforward. This complexity is evident in the equal distribution of the 0‐allele/severe variant c.465+1G&gt;A, p.(?) among late‐juvenile and adult patients in the c.542T&gt;G group, where ASO ranged from 6 to 27 years. Although residual ASA activity was not assessed in this study, it may provide additional predictive insight. Santhanakumaran et al. reported higher residual ASA activity in patients with cognitive disease onset compared to those with motor onset; they were unable to distinguish late‐juvenile from adult onset [<a href="#jimd70072-bib-0016" class="usa-link" aria-describedby="jimd70072-bib-0016">16</a>]. A close correlation between levels of residual ASA activity and ASO has yet to be established [<a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>]. It is possible that (epi)genetic or environmental factors also influence the phenotype of individual patients, even within families [<a href="#jimd70072-bib-0008" class="usa-link" aria-describedby="jimd70072-bib-0008">8</a>].</p>
<p>Biffi et al. hypothesized that the severity of peripheral neuropathy might be an additional tool for predicting clinical severity, suggesting that no or mild demyelinating neuropathy indicates less severe disease progression [<a href="#jimd70072-bib-0014" class="usa-link" aria-describedby="jimd70072-bib-0014">14</a>]. While the majority of patients in this study, which focused on specific genotypes associated with less severe disease progression, exhibited no or mild demyelinating neuropathy, consistent with this hypothesis, normal conduction velocities were also observed in the patients with an early MLD onset and rapid gross motor deterioration.</p>
<p>Interestingly, we did not identify the c.257G&gt;A and c.542T&gt;G variants in homozygous state in this study, neither in previously published MLD patients [<a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>, <a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>, <a href="#jimd70072-bib-0034" class="usa-link" aria-describedby="jimd70072-bib-0034">34</a>, <a href="#jimd70072-bib-0035" class="usa-link" aria-describedby="jimd70072-bib-0035">35</a>]. Therefore, the classification of c.257G&gt;A as a moderate variant, as proposed by Trinidad et al., may need to be reconsidered as a mild variant [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>]. Additionally, no patients compound heterozygous for any combination of the variants c.256C&gt;T, c.257G&gt;A, and c.542T&gt;G have been identified, despite their relatively high frequency [<a href="#jimd70072-bib-0004" class="usa-link" aria-describedby="jimd70072-bib-0004">4</a>, <a href="#jimd70072-bib-0006" class="usa-link" aria-describedby="jimd70072-bib-0006">6</a>, <a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>, <a href="#jimd70072-bib-0034" class="usa-link" aria-describedby="jimd70072-bib-0034">34</a>, <a href="#jimd70072-bib-0036" class="usa-link" aria-describedby="jimd70072-bib-0036">36</a>]. Another intriguing finding is that only one patient in our cohort was compound heterozygous with the mild c.1283C&gt;T, p.(Ser428Phe) as the second <em>ARSA</em> variant, despite its relatively high frequency. One possible explanation for the absence of these genotypes is misdiagnosis as dementia due to late adulthood and absent motor signs. This is supported by a patient compound heterozygous for c.542T&gt;G and c.1283C&gt;T who presented around the age of 60 years with a frontal syndrome, without signs of polyneuropathy or motor impairment. Only NCS indicated mild demyelinating neuropathy [<a href="#jimd70072-bib-0037" class="usa-link" aria-describedby="jimd70072-bib-0037">37</a>, <a href="#jimd70072-bib-0038" class="usa-link" aria-describedby="jimd70072-bib-0038">38</a>]. However, these genotypes have not been reported in large dementia cohorts so far [<a href="#jimd70072-bib-0039" class="usa-link" aria-describedby="jimd70072-bib-0039">39</a>]. Another possibility for the absence of combinations of the three studied variants (c.256C&gt;T, c.257G&gt;A, and c.542T&gt;G) is that these genotypes may lack clinical consequences. The MLD phenotype matrix by Trinidad et al. suggests that individuals with mild/mild (including c.542T&gt;G/c.542T&gt;G) or mild/moderate (including c.542T&gt;G/c.256C&gt;T) genotype combinations may be asymptomatic or have very late or subtle symptom onset [<a href="#jimd70072-bib-0017" class="usa-link" aria-describedby="jimd70072-bib-0017">17</a>]. Further support comes from gnomAD (v4.1.0, accessed 09/2024), which identifies a presumed healthy individual carrying the c.542T&gt;G variant in a homozygous state.</p>
<p>Analyzing these three <em>ARSA</em> variants and related phenotypes demonstrates that detailed phenotype information on disease‐causing <em>ARSA</em> variants (not limited to age of onset but describing long‐term disease course and associated instrumental parameters) is essential to interpret results from newborn screening and to advance phenotype prediction to aid decisions regarding treatment timing and mode [<a href="#jimd70072-bib-0016" class="usa-link" aria-describedby="jimd70072-bib-0016">16</a>]. Although inclusion of later‐onset disorders in NBS is debated, detailed genotype–phenotype correlations can guide individualized decisions and help define actionable cases. In addition, genotype–phenotype associations are crucial for the proper interpretation of treatment effects. Long‐term preservation of motor function is typical for c.257G&gt;A and c.542T&gt;G compound heterozygous and c.256C&gt;T homozygous patients, limiting the value of motor function as a primary outcome in (experimental) treatments concerning this patient group. Instead, preventing severe cognitive decline should be considered the preferred primary outcome and treatment goal. Additionally, MRI severity score seems to be a promising long‐term marker of treatment effects.</p>
<p>Several study limitations deserve mention. Due to study design, we were unable to collect exact times of clinical and radiological deterioration, such as the age of loss of ambulation, limiting Kaplan–Meier analyses. Nevertheless, the long FU periods and the homogeneity in clinical and radiological features of patients compound heterozygous for either c.257G&gt;A or c.542T&gt;G, regardless of the second variant in trans, as well as the significant differences between these patients and those compound heterozygous for c.256C&gt;T with a severe second variant, add robustness to our findings. Some test results were obtained using different methods and reference values, inherent to an international multicenter study spanning two decades. Consequently, residual ASA enzyme activity was not assessed in this study, results of peripheral neuropathy were based on local interpretations, and results of FSIQ were categorized rather than using exact outcomes, which may have induced information bias. This limitation underscores the need for harmonized test protocols in rare diseases often requiring international patient cohorts to achieve sufficient numbers.</p>
<p>As with most retrospective studies, missing data could potentially lead to selection bias. This issue is particularly relevant for cognitive function, as FSIQ testing is rarely performed on patients with severe cognitive impairment. Selective non‐testing may account for the discrepancy between reports of cognitive decline and the relatively high proportion of patients with no to borderline impairment of cognitive function. In addition, patients with leukodystrophies might face behavioral and daily living challenges that are more severe than their cognitive functioning would suggest [<a href="#jimd70072-bib-0040" class="usa-link" aria-describedby="jimd70072-bib-0040">40</a>]. Finally, the study had only a small number of treated patients with a relatively short FU period, who were, on average, younger and less affected than those in the untreated group. This is particularly notable given the slow and late progression of the disease in patients with this genotype. As a result, while the findings suggest differences in cognitive function and MRI severity, definitive conclusions about the HSCT effects cannot be drawn.</p>
<p>In conclusion, despite genetic heterogeneity due to the second variant in trans, patients with MLD harboring the c.257G&gt;A or c.542T&gt;G variant on one allele in <em>ARSA</em> typically exhibit slow disease progression characterized by mainly cognitive decline and long‐term preservation of motor function. The early onset of rapid motor decline in patients harboring the c.256C&gt;T variant on one allele depends on the severity of the second variant in trans. Those who are homozygous for c.256C&gt;T or carry another mild second variant tend to present similarly to patients with c.257G&gt;A or c.542T&gt;G. Patients who are compound heterozygous for any combination of the variants c.256C&gt;T, c.257G&gt;A, c.542T&gt;G, or another mild variant may be asymptomatic or experience very late or subtle symptom onset. This prognosis should be weighed against the risks of HSCT. Furthermore, to evaluate treatment effects in clinical trials in pre‐ and post‐registration studies, cognitive function and MRI severity scores should be preferred as treatment outcomes in patients with these genotypes, as motor function, peripheral nerve function, and survival can be retained for decades. In this cohort, treated patients demonstrated stable cognitive function and MRI severity scores after HSCT. However, larger studies are needed to assess treatment efficacy specifically in patients primarily experiencing cognitive decline. Further research is needed to explore whether other mild <em>ARSA</em> variants are associated with similar phenotypes and to better understand their long‐term clinical course.</p></section><section id="jimd70072-sec-0020"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>Shanice Beerepoot:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data, study concept or design, analysis or interpretation of data. <strong>Daphne H. Schoenmakers:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Francesca Fumagalli:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Samuel Groeschel:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Ludger Schöls:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Raphael Schiffmann:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Sheila Wong:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Odile Boespflug‐Tanguy:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Caroline Sevin:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Yann Nadjar:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Annette Bley:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Fanny Mochel:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Morten A. Horn:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Cristina Baldoli:</strong> analysis or interpretation of data. <strong>Sara Locatelli:</strong> major role in the acquisition of data. <strong>Holger Hengel:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Lucia Laugwitz:</strong> drafting/revision of the manuscript for content, including medical writing for content, analysis or interpretation of data. <strong>Carla E. M. Hollak:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Volkmar Gieselmann:</strong> drafting/revision of the manuscript for content, including medical writing for content; analysis or interpretation of data. <strong>Marjo S. van der Knaap:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data. <strong>Nicole I. Wolf:</strong> drafting/revision of the manuscript for content, including medical writing for content, major role in the acquisition of data; study concept or design.</p></section><section id="jimd70072-sec-0022"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>This study was approved by the local ethics committees of each participating hospital.</p></section><section id="jimd70072-sec-0023"><h2 class="pmc_sec_title">Consent</h2>
<p>Written informed consent was obtained from the patients or their guardians.</p></section><section id="jimd70072-sec-0024"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Nicole I. Wolf is advisor and/or co‐investigator for trials in MLD (Shire/Takeda, Orchard, Evidera) and other leukodystrophies (Ionis, PassageBio, Vigil Neuro), with all payments to the institution. Annette Bley is coinvestigator/advisor for trials in MLD (Shire/Takeda, Orchard). Caroline Sevin is an advisor and/or investigator for trials in MLD (Shire/Takeda, Orchard). Francesca Fumagalli is an investigator of gene therapy clinical trials for MLD sponsored by Orchard Therapeutics, the license holder of Libmeldy, and acts as a consultant for the ad hoc Advisory Board of Orchard Therapeutics and Takeda. Carla E. M. Hollak is involved in premarketing studies with Sanofi, Protalix, and Idorsia, for which financial arrangements are made with Amsterdam UMC Research BV. These activities are unrelated to the content of this manuscript. Ludger Schöls served as a consultant for Vico Therapeutics, Vigil Neuroscience, and Novartis unrelated to MLD and the manuscript. Samuel Groeschel received an Institutional Research Support from Shire plc and Orchard, and is an advisor and coinvestigator for trials in MLD (Shire/Takeda, Orchard) without personal payments. Yann Nadjar received a research grant from Orchard. The other authors declare no conflicts of interest.</p></section><section id="sec24"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="jimd70072-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317651/bin/JIMD-48-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s001.docx</a><sup> (69.2KB, docx) </sup>
</div></div></section></section><section id="jimd70072-sec-0021" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This research includes data generated as part of the MLD Initiative—Disease Registry for Metachromatic Leukodystrophy. The authors thank Carla Butera at the San Raffaele Telethon Institute for Gene Therapy for her assistance in scoring the peripheral neuropathy and Dr. Elaine Kan at the Department of Radiology at the Hong Kong Children's Hospital for her contribution to the radiological assessment of several included patients. The following authors of this publication are members of the European Reference Network for Rare Neurological Diseases (ERN‐RND)—Project ID No 739510: Samuel Groeschel, Ludger Schöls, Caroline Sevin, Odile Boespflug‐Tanguy, Marjo S. van der Knaap, Nicole I. Wolf, Francesca Fumagalli, and Fanny Mochel. The following authors of this publication are members of the European Reference Network for Hereditary Metabolic Disorders (Metab‐ERN): Carla E. M. Hollak, Annette Bley, Fanny Mochel, and Morten A. Horn.</p></section><section id="notes1"><p>

Beerepoot S., Schoenmakers D. H., Fumagalli F., et al., “
<em>ARSA</em> Variants Associated With Cognitive Decline and Long‐Term Preservation of Motor Function in Metachromatic Leukodystrophy,” Journal of Inherited Metabolic Disease
48, no. 5 (2025): e70072, 10.1002/jimd.70072.
</p>
<section id="jimd70072-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="jimd70072-note-0001"><p>
<strong>Communicating Editor:</strong> Areeg ElGharbawy</p></div>
<div class="fn p" id="jimd70072-note-0002"><p>
<strong>Funding:</strong> This study was partially supported by the Dutch charity organization Stichting Metakids (Metakids: 2017‐073 to NIW). Subjects from IRCCS San Raffaele Scientific Institute were enrolled in the “Metachromatic Leukodystrophy observational clinical trial—LDM/1,” a retrospective and prospective natural history study approved by the Institutional Review Board (IRB) of San Raffaele Hospital on July 15th, 2004, and currently ongoing. This study was supported by Telethon Foundation, IRCCS San Raffaele Scientific Institute, GlaxoSmithKline Intellectual Property Development Limited, and Orchard Therapeutics. Subjects from Kinder‐UKE, University Hospital Hamburg Eppendorf were enrolled in the “Study of the clinical course of leukodystrophies” PV3782 approved on 7 November 2011 and 4 September 2020 by the Ethics Committee of the Medical Association of Hamburg, Germany. This study was supported by the nonprofit association “Freundeskreis UKE für Kinder mit Demenz e.V.” (<a href="https://fk-kinderdemenz.de" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fk‐kinderdemenz.de</a>). The work of S.G. and L.S. was supported by a grant of the German Ministry of Health (BMG grant ZMVI1‐2520DAT94E) to the LeukoExpert network. Additionally, S.G. was supported by a German Research Foundation grant (DFG 421769743). H.H. was supported by the Deutsche Forschungsgemeinschaft (DFG, HE8803/1–1).</p></div>
</div></section></section><section id="jimd70072-sec-0026"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Pseudonymized individual data in this article will be made available on reasonable request from a qualified investigator, after approval of the Institutional Review Board of the hospitals that own the data in question.</p></section><section id="jimd70072-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="jimd70072-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="jimd70072-bib-0001">
<span class="label">1.</span><cite>
Gieselmann V. and Krageloh‐Mann I., “Metachromatic Leukodystrophy—An Update,” Neuropediatrics
41, no. 1 (2010): 1–6, 10.1055/s-0030-1253412.
</cite> [<a href="https://doi.org/10.1055/s-0030-1253412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20571983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropediatrics&amp;title=Metachromatic%20Leukodystrophy%E2%80%94An%20Update&amp;author=V.%20Gieselmann&amp;author=I.%20Krageloh%E2%80%90Mann&amp;volume=41&amp;issue=1&amp;publication_year=2010&amp;pages=1-6&amp;pmid=20571983&amp;doi=10.1055/s-0030-1253412&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0002">
<span class="label">2.</span><cite>
Kehrer C., Blumenstock G., Gieselmann V., Krageloh‐Mann I., and German L., “The Natural Course of Gross Motor Deterioration in Metachromatic Leukodystrophy,” Developmental Medicine and Child Neurology
53, no. 9 (2011): 850–855, 10.1111/j.1469-8749.2011.04028.x.
</cite> [<a href="https://doi.org/10.1111/j.1469-8749.2011.04028.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21707604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Developmental%20Medicine%20and%20Child%20Neurology&amp;title=The%20Natural%20Course%20of%20Gross%20Motor%20Deterioration%20in%20Metachromatic%20Leukodystrophy&amp;author=C.%20Kehrer&amp;author=G.%20Blumenstock&amp;author=V.%20Gieselmann&amp;author=I.%20Krageloh%E2%80%90Mann&amp;author=L.%20German&amp;volume=53&amp;issue=9&amp;publication_year=2011&amp;pages=850-855&amp;pmid=21707604&amp;doi=10.1111/j.1469-8749.2011.04028.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0003">
<span class="label">3.</span><cite>
Kehrer C., Groeschel S., Kustermann‐Kuhn B., et al., “Language and Cognition in Children With Metachromatic Leukodystrophy: Onset and Natural Course in a Nationwide Cohort,” Orphanet Journal of Rare Diseases
9, no. 1 (2014): 18, 10.1186/1750-1172-9-18.
</cite> [<a href="https://doi.org/10.1186/1750-1172-9-18" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3922034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24499656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Language%20and%20Cognition%20in%20Children%20With%20Metachromatic%20Leukodystrophy:%20Onset%20and%20Natural%20Course%20in%20a%20Nationwide%20Cohort&amp;author=C.%20Kehrer&amp;author=S.%20Groeschel&amp;author=B.%20Kustermann%E2%80%90Kuhn&amp;volume=9&amp;issue=1&amp;publication_year=2014&amp;pages=18&amp;pmid=24499656&amp;doi=10.1186/1750-1172-9-18&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0004">
<span class="label">4.</span><cite>
Fumagalli F., Zambon A. A., Rancoita P. M. V., et al., “Metachromatic Leukodystrophy: A Single‐Center Longitudinal Study of 45 Patients,” Journal of Inherited Metabolic Disease
44, no. 5 (2021): 1151–1164, 10.1002/jimd.12388.
</cite> [<a href="https://doi.org/10.1002/jimd.12388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33855715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Metachromatic%20Leukodystrophy:%20A%20Single%E2%80%90Center%20Longitudinal%20Study%20of%2045%20Patients&amp;author=F.%20Fumagalli&amp;author=A.%20A.%20Zambon&amp;author=P.%20M.%20V.%20Rancoita&amp;volume=44&amp;issue=5&amp;publication_year=2021&amp;pages=1151-1164&amp;pmid=33855715&amp;doi=10.1002/jimd.12388&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0005">
<span class="label">5.</span><cite>
Sessa M., Lorioli L., Fumagalli F., et al., “Lentiviral Haemopoietic Stem‐Cell Gene Therapy in Early‐Onset Metachromatic Leukodystrophy: An Ad‐Hoc Analysis of a Non‐Randomised, Open‐Label, Phase 1/2Trial,” Lancet
388, no. 10043 (2016): 476–487, 10.1016/S0140-6736(16)30374-9.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)30374-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27289174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Lentiviral%20Haemopoietic%20Stem%E2%80%90Cell%20Gene%20Therapy%20in%20Early%E2%80%90Onset%20Metachromatic%20Leukodystrophy:%20An%20Ad%E2%80%90Hoc%20Analysis%20of%20a%20Non%E2%80%90Randomised,%20Open%E2%80%90Label,%20Phase%201/2Trial&amp;author=M.%20Sessa&amp;author=L.%20Lorioli&amp;author=F.%20Fumagalli&amp;volume=388&amp;issue=10043&amp;publication_year=2016&amp;pages=476-487&amp;pmid=27289174&amp;doi=10.1016/S0140-6736(16)30374-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0006">
<span class="label">6.</span><cite>
Beerepoot S., van Dooren S. J. M., Salomons G. S., et al., “Metachromatic Leukodystrophy Genotypes in The Netherlands Reveal Novel Pathogenic ARSA Variants in Non‐Caucasian Patients,” Neurogenetics
21, no. 4 (2020): 289–299, 10.1007/s10048-020-00621-6.
</cite> [<a href="https://doi.org/10.1007/s10048-020-00621-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7476914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32632536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurogenetics&amp;title=Metachromatic%20Leukodystrophy%20Genotypes%20in%20The%20Netherlands%20Reveal%20Novel%20Pathogenic%20ARSA%20Variants%20in%20Non%E2%80%90Caucasian%20Patients&amp;author=S.%20Beerepoot&amp;author=S.%20J.%20M.%20van%20Dooren&amp;author=G.%20S.%20Salomons&amp;volume=21&amp;issue=4&amp;publication_year=2020&amp;pages=289-299&amp;pmid=32632536&amp;doi=10.1007/s10048-020-00621-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0007">
<span class="label">7.</span><cite>
Beerepoot S., Wolf N. I., Wehner K., et al., “Acute‐Onset Paralytic Strabismus in Toddlers Is Important to Consider as a Potential Early Sign of Late‐Infantile Metachromatic Leukodystrophy,” European Journal of Paediatric Neurology
37 (March 2022): 87–93, 10.1016/j.ejpn.2022.01.020.
</cite> [<a href="https://doi.org/10.1016/j.ejpn.2022.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35152000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Paediatric%20Neurology&amp;title=Acute%E2%80%90Onset%20Paralytic%20Strabismus%20in%20Toddlers%20Is%20Important%20to%20Consider%20as%20a%20Potential%20Early%20Sign%20of%20Late%E2%80%90Infantile%20Metachromatic%20Leukodystrophy&amp;author=S.%20Beerepoot&amp;author=N.%20I.%20Wolf&amp;author=K.%20Wehner&amp;volume=37&amp;publication_year=March%202022&amp;pages=87-93&amp;pmid=35152000&amp;doi=10.1016/j.ejpn.2022.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0008">
<span class="label">8.</span><cite>
Elgun S., Waibel J., Kehrer C., et al., “Phenotypic Variation Between Siblings With Metachromatic Leukodystrophy,” Orphanet Journal of Rare Diseases
14, no. 1 (June 2019): 136, 10.1186/s13023-019-1113-6.
</cite> [<a href="https://doi.org/10.1186/s13023-019-1113-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6560893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31186049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Phenotypic%20Variation%20Between%20Siblings%20With%20Metachromatic%20Leukodystrophy&amp;author=S.%20Elgun&amp;author=J.%20Waibel&amp;author=C.%20Kehrer&amp;volume=14&amp;issue=1&amp;publication_year=June%202019&amp;pages=136&amp;pmid=31186049&amp;doi=10.1186/s13023-019-1113-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0009">
<span class="label">9.</span><cite>
Zambon A. A., Rancoita P. M. V., Quattrini A., et al., “Effects of Atidarsagene Autotemcel Gene Therapy on Peripheral Nerves in Late‐Infantile Metachromatic Leukodystrophy,” Brain (April 2025), 10.1093/brain/awaf157.</cite> [<a href="https://doi.org/10.1093/brain/awaf157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40286327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Effects%20of%20Atidarsagene%20Autotemcel%20Gene%20Therapy%20on%20Peripheral%20Nerves%20in%20Late%E2%80%90Infantile%20Metachromatic%20Leukodystrophy&amp;author=A.%20A.%20Zambon&amp;author=P.%20M.%20V.%20Rancoita&amp;author=A.%20Quattrini&amp;publication_year=April%202025&amp;pmid=40286327&amp;doi=10.1093/brain/awaf157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0010">
<span class="label">10.</span><cite>
Kehrer C., Elgün S., Raabe C., et al., “Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy,” Neurology
96, no. 2 (2021): e255–e266, 10.1212/wnl.0000000000011047.
</cite> [<a href="https://doi.org/10.1212/wnl.0000000000011047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33046606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Association%20of%20Age%20at%20Onset%20and%20First%20Symptoms%20With%20Disease%20Progression%20in%20Patients%20With%20Metachromatic%20Leukodystrophy&amp;author=C.%20Kehrer&amp;author=S.%20Elg%C3%BCn&amp;author=C.%20Raabe&amp;volume=96&amp;issue=2&amp;publication_year=2021&amp;pages=e255-e266&amp;pmid=33046606&amp;doi=10.1212/wnl.0000000000011047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0011">
<span class="label">11.</span><cite>
Schoenmakers D. H., Beerepoot S., van den Berg S., et al., “Modified Delphi Procedure‐Based Expert Consensus on Endpoints for an International Disease Registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy Initiative (MLDi),” Orphanet Journal of Rare Diseases
17 (2022): 48, 10.1186/s13023-022-02189-w.
</cite> [<a href="https://doi.org/10.1186/s13023-022-02189-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8842918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35164810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Modified%20Delphi%20Procedure%E2%80%90Based%20Expert%20Consensus%20on%20Endpoints%20for%20an%20International%20Disease%20Registry%20for%20Metachromatic%20Leukodystrophy:%20The%20European%20Metachromatic%20Leukodystrophy%20Initiative%20(MLDi)&amp;author=D.%20H.%20Schoenmakers&amp;author=S.%20Beerepoot&amp;author=S.%20van%20den%20Berg&amp;volume=17&amp;publication_year=2022&amp;pages=48&amp;pmid=35164810&amp;doi=10.1186/s13023-022-02189-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0012">
<span class="label">12.</span><cite>
Laugwitz L., Schoenmakers D. H., Adang L. A., et al., “Newborn Screening in Metachromatic Leukodystrophy ‐ European Consensus‐Based Recommendations on Clinical Management,” European Journal of Paediatric Neurology
49 (March 2024): 141–154, 10.1016/j.ejpn.2024.03.003.
</cite> [<a href="https://doi.org/10.1016/j.ejpn.2024.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38554683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Paediatric%20Neurology&amp;title=Newborn%20Screening%20in%20Metachromatic%20Leukodystrophy%20%E2%80%90%20European%20Consensus%E2%80%90Based%20Recommendations%20on%20Clinical%20Management&amp;author=L.%20Laugwitz&amp;author=D.%20H.%20Schoenmakers&amp;author=L.%20A.%20Adang&amp;volume=49&amp;publication_year=March%202024&amp;pages=141-154&amp;pmid=38554683&amp;doi=10.1016/j.ejpn.2024.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0013">
<span class="label">13.</span><cite>
Lugowska A., Amaral O., Berger J., et al., “Mutations c.459+1G&gt;A and p.P426L in the ARSA Gene: Prevalence in Metachromatic Leukodystrophy Patients From European Countries,” Molecular Genetics and Metabolism
86, no. 3 (November 2005): 353–359, 10.1016/j.ymgme.2005.07.010.
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2005.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16140556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Genetics%20and%20Metabolism&amp;title=Mutations%20c.459+1G&gt;A%20and%20p.P426L%20in%20the%20ARSA%20Gene:%20Prevalence%20in%20Metachromatic%20Leukodystrophy%20Patients%20From%20European%20Countries&amp;author=A.%20Lugowska&amp;author=O.%20Amaral&amp;author=J.%20Berger&amp;volume=86&amp;issue=3&amp;publication_year=November%202005&amp;pages=353-359&amp;pmid=16140556&amp;doi=10.1016/j.ymgme.2005.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0014">
<span class="label">14.</span><cite>
Biffi A., Cesani M., Fumagalli F., et al., “Metachromatic Leukodystrophy—Mutation Analysis Provides Further Evidence of Genotype‐Phenotype Correlation,” Clinical Genetics
74, no. 4 (October 2008): 349–357, 10.1111/j.1399-0004.2008.01058.x.
</cite> [<a href="https://doi.org/10.1111/j.1399-0004.2008.01058.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18786133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Genetics&amp;title=Metachromatic%20Leukodystrophy%E2%80%94Mutation%20Analysis%20Provides%20Further%20Evidence%20of%20Genotype%E2%80%90Phenotype%20Correlation&amp;author=A.%20Biffi&amp;author=M.%20Cesani&amp;author=F.%20Fumagalli&amp;volume=74&amp;issue=4&amp;publication_year=October%202008&amp;pages=349-357&amp;pmid=18786133&amp;doi=10.1111/j.1399-0004.2008.01058.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0015">
<span class="label">15.</span><cite>
Cesani M., Capotondo A., Plati T., et al., “Characterization of New Arylsulfatase A Gene Mutations Reinforces Genotype‐Phenotype Correlation in Metachromatic Leukodystrophy,” Human Mutation
30, no. 10 (October 2009): E936–E945, 10.1002/humu.21093.
</cite> [<a href="https://doi.org/10.1002/humu.21093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19606494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Characterization%20of%20New%20Arylsulfatase%20A%20Gene%20Mutations%20Reinforces%20Genotype%E2%80%90Phenotype%20Correlation%20in%20Metachromatic%20Leukodystrophy&amp;author=M.%20Cesani&amp;author=A.%20Capotondo&amp;author=T.%20Plati&amp;volume=30&amp;issue=10&amp;publication_year=October%202009&amp;pages=E936-E945&amp;pmid=19606494&amp;doi=10.1002/humu.21093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0016">
<span class="label">16.</span><cite>
Santhanakumaran V., Groeschel S., Harzer K., et al., “Predicting Clinical Phenotypes of Metachromatic Leukodystrophy Based on the Arylsulfatase A Activity and the ARSA Genotype?—Chances and Challenges,” Molecular Genetics and Metabolism
137 (September 2022): 273–282, 10.1016/j.ymgme.2022.09.009.
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2022.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36240581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Genetics%20and%20Metabolism&amp;title=Predicting%20Clinical%20Phenotypes%20of%20Metachromatic%20Leukodystrophy%20Based%20on%20the%20Arylsulfatase%20A%20Activity%20and%20the%20ARSA%20Genotype?%E2%80%94Chances%20and%20Challenges&amp;author=V.%20Santhanakumaran&amp;author=S.%20Groeschel&amp;author=K.%20Harzer&amp;volume=137&amp;publication_year=September%202022&amp;pages=273-282&amp;pmid=36240581&amp;doi=10.1016/j.ymgme.2022.09.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0017">
<span class="label">17.</span><cite>
Trinidad M., Hong X., Froelich S., et al., “Predicting Disease Severity in Metachromatic Leukodystrophy Using Protein Activity and a Patient Phenotype Matrix,” Genome Biology
24, no. 1 (July 2023): 172, 10.1186/s13059-023-03001-z.
</cite> [<a href="https://doi.org/10.1186/s13059-023-03001-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10360315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37480112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biology&amp;title=Predicting%20Disease%20Severity%20in%20Metachromatic%20Leukodystrophy%20Using%20Protein%20Activity%20and%20a%20Patient%20Phenotype%20Matrix&amp;author=M.%20Trinidad&amp;author=X.%20Hong&amp;author=S.%20Froelich&amp;volume=24&amp;issue=1&amp;publication_year=July%202023&amp;pages=172&amp;pmid=37480112&amp;doi=10.1186/s13059-023-03001-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0018">
<span class="label">18.</span><cite>
Beerepoot S., Nierkens S., Boelens J. J., Lindemans C., Bugiani M., and Wolf N. I., “Peripheral Neuropathy in Metachromatic Leukodystrophy: Current Status and Future Perspective,” Orphanet Journal of Rare Diseases
14, no. 1 (November 2019): 240, 10.1186/s13023-019-1220-4.
</cite> [<a href="https://doi.org/10.1186/s13023-019-1220-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6829806/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31684987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Peripheral%20Neuropathy%20in%20Metachromatic%20Leukodystrophy:%20Current%20Status%20and%20Future%20Perspective&amp;author=S.%20Beerepoot&amp;author=S.%20Nierkens&amp;author=J.%20J.%20Boelens&amp;author=C.%20Lindemans&amp;author=M.%20Bugiani&amp;volume=14&amp;issue=1&amp;publication_year=November%202019&amp;pages=240&amp;pmid=31684987&amp;doi=10.1186/s13023-019-1220-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0019">
<span class="label">19.</span><cite>
Baumann N., Turpin J. C., Lefevre M., and Colsch B., “Motor and Psycho‐Cognitive Clinical Types in Adult Metachromatic Leukodystrophy: Genotype/Phenotype Relationships?,” Journal De Physiologie (Paris)
96, no. 3–4 (2002): 301–306, 10.1016/s0928-4257(02)00019-0.</cite> [<a href="https://doi.org/10.1016/s0928-4257(02)00019-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12445909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20De%20Physiologie%20(Paris)&amp;title=Motor%20and%20Psycho%E2%80%90Cognitive%20Clinical%20Types%20in%20Adult%20Metachromatic%20Leukodystrophy:%20Genotype/Phenotype%20Relationships?&amp;author=N.%20Baumann&amp;author=J.%20C.%20Turpin&amp;author=M.%20Lefevre&amp;author=B.%20Colsch&amp;volume=96&amp;issue=3%E2%80%934&amp;publication_year=2002&amp;pages=301-306&amp;pmid=12445909&amp;doi=10.1016/s0928-4257(02)00019-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0020">
<span class="label">20.</span><cite>
Rauschka H., Colsch B., Baumann N., et al., “Late‐Onset Metachromatic Leukodystrophy: Genotype Strongly Influences Phenotype,” Neurology
67, no. 5 (2006): 859–863, 10.1212/01.wnl.0000234129.97727.4d.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000234129.97727.4d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16966551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Late%E2%80%90Onset%20Metachromatic%20Leukodystrophy:%20Genotype%20Strongly%20Influences%20Phenotype&amp;author=H.%20Rauschka&amp;author=B.%20Colsch&amp;author=N.%20Baumann&amp;volume=67&amp;issue=5&amp;publication_year=2006&amp;pages=859-863&amp;pmid=16966551&amp;doi=10.1212/01.wnl.0000234129.97727.4d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0021">
<span class="label">21.</span><cite>
Tylki‐Szymanska A., Berger J., Loschl B., Lugowska A., and Molzer B., “Late Juvenile Metachromatic Leukodystrophy (MLD) in Three Patients With a Similar Clinical Course and Identical Mutation on One Allele,” Clinical Genetics
50, no. 5 (November 1996): 287–292, 10.1111/j.1399-0004.1996.tb02376.x.
</cite> [<a href="https://doi.org/10.1111/j.1399-0004.1996.tb02376.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9007312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Genetics&amp;title=Late%20Juvenile%20Metachromatic%20Leukodystrophy%20(MLD)%20in%20Three%20Patients%20With%20a%20Similar%20Clinical%20Course%20and%20Identical%20Mutation%20on%20One%20Allele&amp;author=A.%20Tylki%E2%80%90Szymanska&amp;author=J.%20Berger&amp;author=B.%20Loschl&amp;author=A.%20Lugowska&amp;author=B.%20Molzer&amp;volume=50&amp;issue=5&amp;publication_year=November%201996&amp;pages=287-292&amp;pmid=9007312&amp;doi=10.1111/j.1399-0004.1996.tb02376.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0022">
<span class="label">22.</span><cite>
Fluharty A. L., Fluharty C. B., Bohne W., von Figura K., and Gieselmann V., “Two New Arylsulfatase A (ARSA) Mutations in a Juvenile Metachromatic Leukodystrophy (MLD) Patient,” American Journal of Human Genetics
49, no. 6 (1991): 1340–1350.
</cite> [<a href="/articles/PMC1686463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1684088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=Two%20New%20Arylsulfatase%20A%20(ARSA)%20Mutations%20in%20a%20Juvenile%20Metachromatic%20Leukodystrophy%20(MLD)%20Patient&amp;author=A.%20L.%20Fluharty&amp;author=C.%20B.%20Fluharty&amp;author=W.%20Bohne&amp;author=K.%20von%20Figura&amp;author=V.%20Gieselmann&amp;volume=49&amp;issue=6&amp;publication_year=1991&amp;pages=1340-1350&amp;pmid=1684088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0023">
<span class="label">23.</span><cite>
Beerepoot S., Heijst H., Roos B., et al., “Neurofilament Light Chain and Glial Fibrillary Acidic Protein Levels in Metachromatic Leukodystrophy,” Brain
145, no. 1 (2021): 105–118, 10.1093/brain/awab304.</cite> [<a href="https://doi.org/10.1093/brain/awab304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8967093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34398223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Neurofilament%20Light%20Chain%20and%20Glial%20Fibrillary%20Acidic%20Protein%20Levels%20in%20Metachromatic%20Leukodystrophy&amp;author=S.%20Beerepoot&amp;author=H.%20Heijst&amp;author=B.%20Roos&amp;volume=145&amp;issue=1&amp;publication_year=2021&amp;pages=105-118&amp;pmid=34398223&amp;doi=10.1093/brain/awab304&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0024">
<span class="label">24.</span><cite>
van Rappard D. F., de Vries A. L. C., Oostrom K. J., et al., “Slowly Progressive Psychiatric Symptoms: Think Metachromatic Leukodystrophy,” Journal of the American Academy of Child and Adolescent Psychiatry
57, no. 2 (February 2018): 74–76, 10.1016/j.jaac.2017.11.017.
</cite> [<a href="https://doi.org/10.1016/j.jaac.2017.11.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29413149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Academy%20of%20Child%20and%20Adolescent%20Psychiatry&amp;title=Slowly%20Progressive%20Psychiatric%20Symptoms:%20Think%20Metachromatic%20Leukodystrophy&amp;author=D.%20F.%20van%20Rappard&amp;author=A.%20L.%20C.%20de%20Vries&amp;author=K.%20J.%20Oostrom&amp;volume=57&amp;issue=2&amp;publication_year=February%202018&amp;pages=74-76&amp;pmid=29413149&amp;doi=10.1016/j.jaac.2017.11.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0025">
<span class="label">25.</span><cite>
Patel D. R., Apple R., Kanungo S., and Akkal A., “Intellectual Disability: Definitions, Evaluation and Principles of Treatment,” Pediatric Medicine
1 (2018): 11, 10.21037/pm.</cite> [<a href="https://doi.org/10.21037/pm" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Medicine&amp;title=Intellectual%20Disability:%20Definitions,%20Evaluation%20and%20Principles%20of%20Treatment&amp;author=D.%20R.%20Patel&amp;author=R.%20Apple&amp;author=S.%20Kanungo&amp;author=A.%20Akkal&amp;volume=1&amp;publication_year=2018&amp;pages=11&amp;doi=10.21037/pm&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0026">
<span class="label">26.</span><cite>
Groeschel S., Kuhl J. S., Bley A. E., et al., “Long‐Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients,” JAMA Neurology
73, no. 9 (September 2016): 1133–1140, 10.1001/jamaneurol.2016.2067.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2016.2067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27400410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurology&amp;title=Long%E2%80%90Term%20Outcome%20of%20Allogeneic%20Hematopoietic%20Stem%20Cell%20Transplantation%20in%20Patients%20With%20Juvenile%20Metachromatic%20Leukodystrophy%20Compared%20With%20Nontransplanted%20Control%20Patients&amp;author=S.%20Groeschel&amp;author=J.%20S.%20Kuhl&amp;author=A.%20E.%20Bley&amp;volume=73&amp;issue=9&amp;publication_year=September%202016&amp;pages=1133-1140&amp;pmid=27400410&amp;doi=10.1001/jamaneurol.2016.2067&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0027">
<span class="label">27.</span><cite>
Kehrer C., Blumenstock G., Raabe C., and Krägeloh‐Mann I., “Development and Reliability of a Classification System for Gross Motor Function in Children With Metachromatic Leucodystrophy,” Developmental Medicine and Child Neurology
53, no. 2 (February 2011): 156–160, 10.1111/j.1469-8749.2010.03821.x.
</cite> [<a href="https://doi.org/10.1111/j.1469-8749.2010.03821.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21087233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Developmental%20Medicine%20and%20Child%20Neurology&amp;title=Development%20and%20Reliability%20of%20a%20Classification%20System%20for%20Gross%20Motor%20Function%20in%20Children%20With%20Metachromatic%20Leucodystrophy&amp;author=C.%20Kehrer&amp;author=G.%20Blumenstock&amp;author=C.%20Raabe&amp;author=I.%20Kr%C3%A4geloh%E2%80%90Mann&amp;volume=53&amp;issue=2&amp;publication_year=February%202011&amp;pages=156-160&amp;pmid=21087233&amp;doi=10.1111/j.1469-8749.2010.03821.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0028">
<span class="label">28.</span><cite>
van Rappard D. F., Konigs M., Steenweg M. E., et al., “Diffusion Tensor Imaging in Metachromatic Leukodystrophy,” Journal of Neurology
265, no. 3 (March 2018): 659–668, 10.1007/s00415-018-8765-3.
</cite> [<a href="https://doi.org/10.1007/s00415-018-8765-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5834549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29383515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology&amp;title=Diffusion%20Tensor%20Imaging%20in%20Metachromatic%20Leukodystrophy&amp;author=D.%20F.%20van%20Rappard&amp;author=M.%20Konigs&amp;author=M.%20E.%20Steenweg&amp;volume=265&amp;issue=3&amp;publication_year=March%202018&amp;pages=659-668&amp;pmid=29383515&amp;doi=10.1007/s00415-018-8765-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0029">
<span class="label">29.</span><cite>
Strolin M., Krageloh‐Mann I., Kehrer C., Wilke M., and Groeschel S., “Demyelination Load as Predictor for Disease Progression in Juvenile Metachromatic Leukodystrophy,” Annals of Clinical Translational Neurology
4, no. 6 (June 2017): 403–410, 10.1002/acn3.420.
</cite> [<a href="https://doi.org/10.1002/acn3.420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5454396/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28589167/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Clinical%20Translational%20Neurology&amp;title=Demyelination%20Load%20as%20Predictor%20for%20Disease%20Progression%20in%20Juvenile%20Metachromatic%20Leukodystrophy&amp;author=M.%20Strolin&amp;author=I.%20Krageloh%E2%80%90Mann&amp;author=C.%20Kehrer&amp;author=M.%20Wilke&amp;author=S.%20Groeschel&amp;volume=4&amp;issue=6&amp;publication_year=June%202017&amp;pages=403-410&amp;pmid=28589167&amp;doi=10.1002/acn3.420&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0030">
<span class="label">30.</span><cite>
Eichler F., Grodd W., Grant E., et al., “Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging Observations,” AJNR. American Journal of Neuroradiology
30, no. 10 (November 2009): 1893–1897, 10.3174/ajnr.A1739.
</cite> [<a href="https://doi.org/10.3174/ajnr.A1739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7051299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19797797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AJNR.%20American%20Journal%20of%20Neuroradiology&amp;title=Metachromatic%20Leukodystrophy:%20A%20Scoring%20System%20for%20Brain%20MR%20Imaging%20Observations&amp;author=F.%20Eichler&amp;author=W.%20Grodd&amp;author=E.%20Grant&amp;volume=30&amp;issue=10&amp;publication_year=November%202009&amp;pages=1893-1897&amp;pmid=19797797&amp;doi=10.3174/ajnr.A1739&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0031">
<span class="label">31.</span><cite>
Lukatela G., Krauss N., Theis K., et al., “Crystal Structure of Human Arylsulfatase A: The Aldehyde Function and the Metal Ion at the Active Site Suggest a Novel Mechanism for Sulfate Ester Hydrolysis,” Biochemistry
37, no. 11 (March 1998): 3654–3664, 10.1021/bi9714924.
</cite> [<a href="https://doi.org/10.1021/bi9714924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9521684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Crystal%20Structure%20of%20Human%20Arylsulfatase%20A:%20The%20Aldehyde%20Function%20and%20the%20Metal%20Ion%20at%20the%20Active%20Site%20Suggest%20a%20Novel%20Mechanism%20for%20Sulfate%20Ester%20Hydrolysis&amp;author=G.%20Lukatela&amp;author=N.%20Krauss&amp;author=K.%20Theis&amp;volume=37&amp;issue=11&amp;publication_year=March%201998&amp;pages=3654-3664&amp;pmid=9521684&amp;doi=10.1021/bi9714924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0032">
<span class="label">32.</span><cite>
Kappler J., von Figura K., and Gieselmann V., “Late‐Onset Metachromatic Leukodystrophy: Molecular Pathology in Two Siblings,” Annals of Neurology
31, no. 3 (March 1992): 256–261, 10.1002/ana.410310305.
</cite> [<a href="https://doi.org/10.1002/ana.410310305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1353340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Neurology&amp;title=Late%E2%80%90Onset%20Metachromatic%20Leukodystrophy:%20Molecular%20Pathology%20in%20Two%20Siblings&amp;author=J.%20Kappler&amp;author=K.%20von%20Figura&amp;author=V.%20Gieselmann&amp;volume=31&amp;issue=3&amp;publication_year=March%201992&amp;pages=256-261&amp;pmid=1353340&amp;doi=10.1002/ana.410310305&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0033">
<span class="label">33.</span><cite>
van Rappard D. F., Boelens J. J., van Egmond M. E., et al., “Efficacy of Hematopoietic Cell Transplantation in Metachromatic Leukodystrophy: The Dutch Experience,” Blood
127, no. 24 (June 2016): 3098–3101, 10.1182/blood-2016-03-708479.
</cite> [<a href="https://doi.org/10.1182/blood-2016-03-708479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27118454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Efficacy%20of%20Hematopoietic%20Cell%20Transplantation%20in%20Metachromatic%20Leukodystrophy:%20The%20Dutch%20Experience&amp;author=D.%20F.%20van%20Rappard&amp;author=J.%20J.%20Boelens&amp;author=M.%20E.%20van%20Egmond&amp;volume=127&amp;issue=24&amp;publication_year=June%202016&amp;pages=3098-3101&amp;pmid=27118454&amp;doi=10.1182/blood-2016-03-708479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0034">
<span class="label">34.</span><cite>
Cesani M., Lorioli L., Grossi S., et al., “Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy,” Human Mutation
37, no. 1 (January 2016): 16–27, 10.1002/humu.22919.
</cite> [<a href="https://doi.org/10.1002/humu.22919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26462614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Mutation%20Update%20of%20ARSA%20and%20PSAP%20Genes%20Causing%20Metachromatic%20Leukodystrophy&amp;author=M.%20Cesani&amp;author=L.%20Lorioli&amp;author=S.%20Grossi&amp;volume=37&amp;issue=1&amp;publication_year=January%202016&amp;pages=16-27&amp;pmid=26462614&amp;doi=10.1002/humu.22919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0035">
<span class="label">35.</span><cite>
Karczewski K. J., Francioli L. C., Tiao G., et al., “The Mutational Constraint Spectrum Quantified From Variation in 141,456 Humans,” Nature
581, no. 7809 (May 2020): 434–443, 10.1038/s41586-020-2308-7.
</cite> [<a href="https://doi.org/10.1038/s41586-020-2308-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7334197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20Mutational%20Constraint%20Spectrum%20Quantified%20From%20Variation%20in%20141,456%20Humans&amp;author=K.%20J.%20Karczewski&amp;author=L.%20C.%20Francioli&amp;author=G.%20Tiao&amp;volume=581&amp;issue=7809&amp;publication_year=May%202020&amp;pages=434-443&amp;pmid=32461654&amp;doi=10.1038/s41586-020-2308-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0036">
<span class="label">36.</span><cite>
Lugowska A., Poninska J., Krajewski P., Broda G., and Ploski R., “Population Carrier Rates of Pathogenic ARSA Gene Mutations: Is Metachromatic Leukodystrophy Underdiagnosed?,” PLoS One
6, no. 6 (2011): e20218, 10.1371/journal.pone.0020218.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0020218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3112151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21695197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Population%20Carrier%20Rates%20of%20Pathogenic%20ARSA%20Gene%20Mutations:%20Is%20Metachromatic%20Leukodystrophy%20Underdiagnosed?&amp;author=A.%20Lugowska&amp;author=J.%20Poninska&amp;author=P.%20Krajewski&amp;author=G.%20Broda&amp;author=R.%20Ploski&amp;volume=6&amp;issue=6&amp;publication_year=2011&amp;pages=e20218&amp;pmid=21695197&amp;doi=10.1371/journal.pone.0020218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0037">
<span class="label">37.</span><cite>
Duyff R. F. and Weinstein H. C., “Late‐Presenting Metachromatic Leukodystrophy,” Lancet
348, no. 9038 (November 1996): 1382–1383, 10.1016/S0140-6736(05)65446-3.</cite> [<a href="https://doi.org/10.1016/S0140-6736(05)65446-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8918293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Late%E2%80%90Presenting%20Metachromatic%20Leukodystrophy&amp;author=R.%20F.%20Duyff&amp;author=H.%20C.%20Weinstein&amp;volume=348&amp;issue=9038&amp;publication_year=November%201996&amp;pages=1382-1383&amp;pmid=8918293&amp;doi=10.1016/S0140-6736(05)65446-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0038">
<span class="label">38.</span><cite>
Perusi C., Lira M. G., Duyff R. F., et al., “Mutations Associated With Very Late‐Onset Metachromatic Leukodystrophy,” Clinical Genetics
55, no. 2 (February 1999): 130, 10.1034/j.1399-0004.1999.550211.x.
</cite> [<a href="https://doi.org/10.1034/j.1399-0004.1999.550211.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10189092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Genetics&amp;title=Mutations%20Associated%20With%20Very%20Late%E2%80%90Onset%20Metachromatic%20Leukodystrophy&amp;author=C.%20Perusi&amp;author=M.%20G.%20Lira&amp;author=R.%20F.%20Duyff&amp;volume=55&amp;issue=2&amp;publication_year=February%201999&amp;pages=130&amp;pmid=10189092&amp;doi=10.1034/j.1399-0004.1999.550211.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0039">
<span class="label">39.</span><cite>
Andrews S. J., Renton A. E., Fulton‐Howard B., Podlesny‐Drabiniok A., Marcora E., and Goate A. M., “The Complex Genetic Architecture of Alzheimer's Disease: Novel Insights and Future Directions,” eBioMedicine
90 (2023): 104511.
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2023.104511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10024184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36907103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eBioMedicine&amp;title=The%20Complex%20Genetic%20Architecture%20of%20Alzheimer's%20Disease:%20Novel%20Insights%20and%20Future%20Directions&amp;author=S.%20J.%20Andrews&amp;author=A.%20E.%20Renton&amp;author=B.%20Fulton%E2%80%90Howard&amp;author=A.%20Podlesny%E2%80%90Drabiniok&amp;author=E.%20Marcora&amp;volume=90&amp;publication_year=2023&amp;pages=104511&amp;pmid=36907103&amp;doi=10.1016/j.ebiom.2023.104511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70072-bib-0040">
<span class="label">40.</span><cite>
Schoenmakers D. H., van Beelen I., Voermans M. M. C., et al., “Adaptive Behavior Assessed by Vineland‐3 as Comprehensive Outcome Measure in Vanishing White Matter,” Annals of Clinical Translational Neurology
11, no. 3 (March 2024): 650–661, 10.1002/acn3.51985.
</cite> [<a href="https://doi.org/10.1002/acn3.51985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10963295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38217081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Clinical%20Translational%20Neurology&amp;title=Adaptive%20Behavior%20Assessed%20by%20Vineland%E2%80%903%20as%20Comprehensive%20Outcome%20Measure%20in%20Vanishing%20White%20Matter&amp;author=D.%20H.%20Schoenmakers&amp;author=I.%20van%20Beelen&amp;author=M.%20M.%20C.%20Voermans&amp;volume=11&amp;issue=3&amp;publication_year=March%202024&amp;pages=650-661&amp;pmid=38217081&amp;doi=10.1002/acn3.51985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317651/bin/JIMD-48-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s001.docx</a><sup> (69.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Pseudonymized individual data in this article will be made available on reasonable request from a qualified investigator, after approval of the Institutional Review Board of the hospitals that own the data in question.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Inherited Metabolic Disease are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/jimd.70072"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/JIMD-48-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12317651/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12317651/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12317651%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317651/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12317651/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12317651/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40751594/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12317651/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40751594/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12317651/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12317651/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="WI1gz1SHoFM9pQ4tZiUn72PcBOLJBW0fU31SQNvLYs3xWDnBfT2Dt2Bzi87luWVa">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
